Effect of KBGG in The Management of Bhrama (Hypertension)

“THE EFFECT OF “KARPASA BEEJADI GRITHA GUTIKA” IN
THE MANAGEMENT OF BHRAMA W.S.R. TO HYPERTENSION”
Dissertation submitted in partial fulfillment for the degree of
DOCTOR OF MEDICINE (AYURVEDA)

In
“KAYACHIKITSA”
By
Dr.B.ARUN KUMAR.
B.A.M.S
GUIDE
Dr. V. VIJAYA BABU.

M.D. (Ay.)
Reader,
Postgraduate Department of Kayachikitsa,
Dr. B.R.K.R. Govt.Ayurvedic College,
Hyderabad.
Dr. N.T.R UNIVERSITY OF HEALTH SCIENCES, VIJAYAWADA

Dr.B.R.K.R. GOVT.AYURVEDIC COLLEGE,
HYDERABAD.
2008
created by technoayurveda.wordpress.com of Dr.KSRPrasad

Dr. N.T.R. UNIVERSITY OF HEALTH SCIENCES,
VIJAYAWADA.
POST GRADUATE TRAINING AND RESEARCH UNIT
DEPARTMENT OF KAYACHIKITSA
Dr. B.R.K.R. GOVT. AYURVEDIC COLLEGE / HOSPITAL,
HYDERABAD.
CERTIFICATE
This is to certify that the present dissertation embodies the outcome of original
observations made by Dr. B.Arun kumar on “The effect of Karpasa beejadi Gritha
Gutika in the management of ‘Bhrama’ w.s.r. to Hypertension” for the degree of
‘Doctor of Medicine’ (Ayurveda) . This work has been completed under my direct
supervision after a series of a scientific discussion.
The scholar has put in commendable effort for designing and executing the methods and
plans for the study. The results achieved through this work are authentic and reproducible. Hence I
recommend this dissertation to be submitted for adjudication.
GUIDE
Date: Dr. V. VIJAYA BABU

Place: Hyderabad. MD (Ayu)
Reader
Post graduate Department of Kayachikitsa,
Dr. B.R.K.R. Govt. Ayurvedic College,
Hyderabad.

Dr. N.T.R. UNIVERSITY OF HEALTH SCIENCES,
VIJAYAWADA.
POST GRADUATE TRAINING AND RESEARCH UNIT
DEPARTMENT OF KAYACHIKITSA
Dr. B.R.K.R. GOVT. AYURVEDIC COLLEGE / HOSPITAL,
HYDERABAD.
CERTIFICATE
This is to certify that Dr. B.Arun kumar of M.D. (Ayu) Kayachikitsa has worked for the
thesis on the topic ‘The effect of Karpasa beejadi Gritha Gutika in the management of Bhrama
w.s.r. to Hypertension’ as per requirements of the order laid by the N.T.R. University of Health
Sciences, for the purpose. The hypothesis submitted by him in the first year MD (Ayu) is one and
the same to that of the dissertation submitted.
I am fully satisfied with his work and hereby forward the dissertation for the evaluation of
the adjudicators.
Date: Dr.PRAKASH CHANDER

Place: Hyderabad MD (Ayu)
Professor& HOD,
Post graduate Dept. of Kayachikitsa
Dr. B.R.K.R. Govt. Ayurvedic College,
Hyderabad.

ACKNOWLEDGEMENT
I take utmost pleasure and feel privileged to express my deep sense of gratitude
and extreme indebtedness to my Guru and Guide Dr. V. VIJAYA BABU, M.D. (Ayu),
Reader, Post Graduate Dept. of Kayachikitsa, Dr. B.R.K.R. Govt. Ayurvedic College,
Hyderabad for his constant and valuable guidance, encouragement throughout the
dissertation work. Undoubtedly the correct, affectionate and untiring guidance of my
Guru has been a greatest asset in its completion.
I express my heartful gratitude to Dr. PRAKASH CHANDER, MD (Ayu), Professor and HOD,
PG Dept. of Kayachikitsa, Dr. B.R.K.R. Govt. Ayurvedic College, Hyderabad, for his constant support,
guidance, encouragement and kind co-operation in all aspects.
I convey my wholehearted thanks and sincere respect to Dr. V.V.S.Ramashastry,

Dr.M.L.Naidu and Dr.Vasudeva rao, former Guides who guided me in this work.
I take this opportunity to express my sincere thanks to Dr P. Nageswar Babu, Dr. S.

Ramalingheswar Rao Technical Assistants, Post Graduate Department of Kayachikitsa,
for their kind co-operation in my clinical work.
I am highly indebted to Dr.K. VijayaLakshmi, for her valuable suggestions being a co-
guide for my work.
I pay my sincere respect to Dr. M. Sadashiva Rao, principal of Dr. B.R.K.R Govt.
Ayurvedic College, Hyderabad for providing facilities for the research work.
I am thankful to Dr. V.L.N.Shastry, Superintendent, Govt.Ayurvedic Hospital,

Erragadda, Hyderabad, for permitting me to conduct research work in the Hospital.
I am highly thankful to Dr. V. Anantsayanachari, HOD of P.G. Dept. of S.S.P and

Dr. M. Philip Anand Kumar, HOD of P.G. Dept. of Dravyaguna for his kindly co-
operation.

I cordially acknowledge my friends and colleagues Dr. K.Srinivasulu, Dr. Namratha,
Dr. Shirisha, Dr. R.Krishna kumar,Dr.B.Kishan,Dr.A. Yadagir,Dr.Kandagatla and
others who helped me in one way or other in completing this work.
I bow my head on the feet of my mother and father. Due regards My wife Dr.B.Shilpa, my
brothers B.Prasad kumar,B.pradeep kumar and my son Mr. Shashank who always stand
with me in each and every moments of my life. My love and appreciations to my all
nephews and nieces for standing with me all time with love affection and patience.
I am highly grateful to the authors of all the books and articles which were utilized by me
as the source of information in the preparation of this thesis.
Lastly I am thankful to all my patients for volunteering trial and all those persons, who
have helped me directly or indirectly for this project work.
Dr.B. Arun kumar.

Date:
Place: Hyderabad

LIST OF TABLES:
S.No. Title of the table Page No.

1. Table showing the external features of the heart 11
2. Diagram showing difference between artery and vein. 16
3. Illustration showing the blood pressure regulation. 20
4. Illustration showing the ‘rennin-angiotensin system’. 23
5. Showing the phases of ‘korotkoff sounds’ 28
6. Schematic representation of ‘samprapthi of bhrama’ with special 56
references to hypertension.
7. Table showing the hypothetical scheme for the pathogenesis of 65
essential hypertension.
8. Table showing initiation of modern treatment in patients with 78
hypertension.
9. Table showing classification and management for Adults 80
9. Table showing picture of individual drugs 92
10. Incidence of sex 101
11. Incidence of age 102
12. Incidence of religion 103
13. Incidence of marital status 104
14. Incidence of occupation 105
15. Incidence of socioeconomic status 106
16. Incidence of food habits 107
17. Incidence of addictions 108
18. Incidence of family history 110
19. Incidence of availability 111
20. Incidence of habitate 112
21. Incidence of severity before treatment 113
22. Incidence of obesity 114
23. Incidence of chronicity 115
24. Incidence of prakriti 116
25. Incidence of stress 117
26. Incidence of diabetes mellitus association 118
27. Incidence of using other drug 120
28. Table showing the subjective parameter bhrama 122
29. Table showing the subjective parameter Shirahshula 123
30. Table showing the subjective parameter Anidra 123
31. Table showing the subjective parameter Over all symptoms 123
32. Table showing results based on subjective parameter 124
33. Table showing results based on systolic blood pressure 125
34. Table showing results based on diastolic blood pressure 126
35. Table showing results based on objective parameter. 127

INDEX
Page no.
 Introduction 1.
 Historical Aspect 3.
PART-A: Shaariram
1) Anatomy of Heart and Blood vessels. 08

2) Physiology of blood circulation. 17
3) Regulation of blood pressure. 20
4) Measurement of blood pressure. 25
PART-B: Disease Aspect
1) Nirukthi & Paribhasha of “Bhrama” 29

2) Nidana. 33
3) Purvarupa. 46
4) Rupa. 47
5) Samprapthi. 50
6) Sapeksha nidana. 69
7) Upadrava. 71
8) Diagnosis and Assessment. 73
9) Chikitsa. 75
10)Pathya-Apathyas 82

PART-C: Drug Profile
1) Criteria for the selection of the drugs 83

2) Description of the individual drugs 84
3) Mode of preparation of compound drug and
administration. 94
PART-D: Clinical study.
1) Materials and Methods 95

2) Observations and Results 99
3) Discussion 128
4) Conclusion 136
5) Summary 138
Bibliography. 139
Annexure. 146

1
INTRODUCTION
The word “Hypertension” is a hybrid of the greek and Latin origin means” Over
stretching of the arteries”. This malady is mostly observed in civilized societies or literate
persons. Who generally force increased socioeconomic stress and strain, irregular dietary
habits and competitive profit motivated, industrialized way of life, so that it is called as a
disease of high pressure society. If it is untreated hypertension takes twenty years off the
average life expected. Where males are far worse than females. Hypertension doesn’t
matter for itself but its outcome, so that it is nicknamed as “silent killer” in aim of the
consequences, along with the increasing of upper age groups of population. However
hypertension became the most common cardiovascular disorder.
It is an established fact that heart and blood vessels are directly involved in
hypertension but it may be essential or secondary, whatever may be role of various
hormones, baroreceptors, chemoreceptors, sodium, blood volume, and viscosity, renin
angiotensive system, vascular disease(Atherosclerosis),vascular reactivity.
Regarding the hypertension one can’t find out the word corresponding to it in
ayurveda. Charaka mentioned that vata, pitta, kapha only cause the nija vyadhis. He
mentioned “Bhrama” in Vataja nanatmaja vyadhis. Sushrutha stated that without dosha,
there will be no disease, by this dosha predominance, in their capacity to produce the
disease can be observed in accordance to their lakshanas for the causation of any disease,
pertaining to the thri vidha roga margas, vata holds responsibility, without vata, there will
be no disease. Even pitta and kaphaja vyadhis that too, the lakshanas enlisted for the
disease hypertension are showing the vata and pitta predominance like
“bhrama”,rakvavritha vata,Pittavrita vata etc.,
The ultimate results are 2, i) increased cardiac output and ii) increased peripheral
resistance, unless these two symptoms are there in hypertension that cannot be considered
according to modern and ayurveda.

2
However a critical and careful study of the ayurvedic classics confirms that
hypertension is merely a collective concept for a number of conditions having in common
the positive characters of arterial hypertension like Raktavrita vata or Raktagata vata,
siravata, Pittavrita vata,Kaphavrita vyana vata.
Hypertension which pertains to sakhas (tissues) is a bahyaroga marga disease.But

it may involve the madhyama roga marga also comprising the three vital organs or
marmas like basti, siras and hridaya.
All most all surveys show that blood pressure rises with age in both men and
women. A national study showed that 76% of the male hypertensive and 88%of females
were in the age group of 25-60yrs.Framingham study showed that an average of 20-
mmofHg systolic and 10mmofHg diastolic increase from age 30-65yr.
Hypertension is one of the most important modifiable risk factors for coronary
heart disease in western and Asian population. Studies from India have shown an
increasing trend in the prevalence of hypertension. Community surveys have documented
that in a period of three to sex decades, prevalence of hypertension has increased about
30 times among urban dwellers and by about 10 times among the rural inhabitants. The
various studies estimated a prevalence rate of hypertension among urban population
ranging from 1.24%in 1949to 36.4%in 2003, and for rural people from 1.99%in 1958 to
21.21%in 1994. The sentinel surveillance project documented 28% overall prevalence of
hypertension (Criteria=JNCVI) from 10 regions of the country in the age group 20-69.
The present study is “The Effect of Karpasabeejadi Gritha Gutika” in the

management of “bhrama” w.s.r. to Hypertension”. To assess the efficacy of the drug in
the maintenance and management of bhrama i.e., Hypertension and the effect of relief
giving in subjective symptoms i.e., relief in bhrama, headache and sleeplessness etc,

3
HISTORICAL ASPECT:
If you just look back to the past days the clinical entity of hypertension is not
available as such in any of the classical literatures of ayurveda. We find more than
thousands of diseases described in ayurveda which can be correlated or resembles one or
the other modern diseases like jwara, rajayakshma, vvisarpa, switra etc., to that of fever,
tuberculosis, herpes, leucodermas etc., respectively. On the contrary it is difficult to find
a clearcut correlation to that of hypertension in our science. But looking to the description
of hridaya, the disease like hridroga, pakshagatha which can be taken as the
complications of hypertension and the drugs like sarpagandha, arjuna etc., we can think
of hypertension to be present in those days.
PREVEDIC PERIOD:
In prevedic period we don’t find any reference regarding hridroga, hrudaya or any
cross references regarding hypertension.
VEDIC PERIOD:
In vedic period we do find references in “atharvaveda” regarding hrudaya,sira,
dhamani,rasa samvahana and the diseases like hridaya, pakshagatha etc., and we can see
some special treatments adopted for these. From this point of view we can think of
hypertension to be present in those days.
PURANA AND UPANISHA PERIOD:

In purana and Upanishads also we cone across the descriptions regarding the
hridaya its disorders etc., in agni purana, skandapurana, mandookopanishad, katopanisha
etc.,
SAMHITA PERIOD:
The description of“Bhrama” in so many disorders is discussed in Charaka samhita
and Sushritha samhita. In “Charaka” the most references are seen in Chikitsa stana,
Vimana and nidana stana. During the treatment of bhrama in so many places grithas are

4
described by charaka. eg., Rohinyadi gritha, Triphaladi gritham and Duralabhadi gritha.
In vatarakta and trishna chapters’ bhrama mentioned as a upadrava. Most of the
descriptions of bhrama are seen in jwara chapter by charaka.
In “sushritha samhita” the most of the descriptions are seen in sutrastana only.The
scientific era of ayurvedic medicine is the samhita kala in this kala the most scientific
approach and thoughts evolved regarding disease, treatment and basic principles etc.,
Some of the samhitas like charaka samhita, sushrita samhita, kashyapa samnita,
bhela samhita were popular during that period. In all these we get references regarding
hridaya, siradhamani, rasa samvahanaie, circulating mechanism and its disorders. Along
with these some of the disorders which are correlated by present day authors, based on
the modern clinical features of hypertension like raktavrita vata, raktagata vata, avrita
vata, dhamani pratichaya etc., are also available in these samhitas.
Even acharya charaka while mentioning the upadravas of avrita vata in chikitsa
stana 28th chapter he mentions “hridroga” as one among them. This suggests that achrya
had the idea regarding hypertension.
According to one of the well known modern physiology author dr.choudhary in

his book “concise medical physiology” describes hypertension is an ancient disease more
than 2500 yrs ago, charaka the father of Hindu system of medicine, described the
condition admirably. But here the author is not clear regarding the context or reference in
charaka samhita.
Supporting the above view it is found that based on the dissection of ancient
Egyptian mummies high blood pressure has been a health problem since at early
Egyptian empires. And in the yellow emperor classics, 2600 BC ago. It is found “the
blood current flow continuously and never stops and if too much salt is used the pulse
hardens.

5
Regarding understanding and concept of this disease rather than to say they did
not had the knowledge or concept we can say that they did not thought much regarding
this since it was not the major problem or disease during those days. Because of the
following reasons.
i)The people during these days used to line in agrarian civilization where they had
enough time to follow daily routines like dhinacharya, rutucharya, sadvritta etc.,
ii)As such there was no industrial civilization and there fore mental stress was not
seen as much as in the present days. This may be one of the reasons for the disease not
being found.
For want of above reasons the disease probably did not manifest so rapidly so as
to attract the attention of the medical people. Therefore no specific description about a
disease resembling hypertension is found in classical literatures.
Apart from this the instruments like sphygmomanometer, electric device or
automated ambulatory blood pressure devices were not there during those days which is
of prime importance in detection of hypertension in asymptomatic.
However it does not mean that a disease not described in our science cannot be
seen at any time in future. Probably our “acharyas” had the intuition that kind of diseases
may manifest or develop in future due to various changes in environmental, cultural or
socioeconomic factors etc.,
Acharya charaka and sushritha have explained beautifully regarding approach of

such diseases i.e., the physician should not get disheartened if he does not know the name
of a disease, instead he should try to collect the information with regards to signs and
symptoms, causes and relate them to tridoshas ie., they mean to say that the concept of
that particular disease should be understood.
After deciding the relation between doshas and an unknown disease, on the basis
of above lakshanas or features the physician should chart out the management of doshas.
This as a guiding principle can help us theoretically to evolve the etiopathogenisis and its
management.

6
SANGRAHA PERIOD:
In this period the one of the most popular book is “Astanga hridaya”. In this book
the description of “bhrama” is seen in so many places i.e.,jwara, visarpa, raktapitta,
Pittaja kasa,Pitta and sannipataja udara,Vataja murcha and Vataja trishna.
This period has been regarded as an “era of inflorescence” of Indian medicine.

Astanga sangraha and astanga hridaya are the granthas of this period. Even in these two
also we do get references regarding the avrita vata and other correlated diseases at
different contexts.
COMPILATION PERIOD:
“Madhava nidana” describes bhrama in various chapters with different context.
He mentioned bhrama as asadya lakshana in madatyaya. It is mentioned as upadrava for
ajirna, vatarakta, amavata and hridroga. In “Sharangadhara samhita” bhrama mentioned
as one of the bheda of murcha.
In this period we find books like madhava nidana, sharangadhara, yogaratnakara

etc., even in these books we do get references regarding the avrita vata and other
correlated diseases which are dealt at later stage.
ADHUNIKA KALA:
The history of hypertension dates back to 16 th century when disease of the heart
and blood vessels were recognized after post mortem examination. When church began to
permit autopsies. But it was in the 2nd century AD. Gallen described almost all the
abnormalities of pulse recognized today which can be thought of here. The arterial blood
pressure gained importance in medical science after “Stephen hales” first measured it in
1733. The blood pressure cuff was invented in 1896. A little more than 100 yr “Riva
rocci” invented the clinical sphygmomanometer and almost 100yr since “korotkoff”
described the auscultatory sounds, major changes in this most commonly performed
procedure in clinical medicine are underway.

7
It was not until the 1950’s that we become aware of the importance of high blood
pressure as a herald of the complications commonly attributed to old age. Regarding the
treatment modern era of antihypertensive therapy began only a little over 50yr ago. With
the pioneering work of “Freis” in the unitedstates and “Smirk” in Newzeland regarding
the level of blood pressure. Sir george pickering in 1972restated that there is no dividing
line between normal and high blood pressure the higher the pressure worse the prognosis.
Presently hypertension is the major risk factor in the development atherosclerotic

IHD and cerebrovascular disease. The researches on this are still going on with to days
update as tomorrows outdate.
th
In this adhunika kala our 20 century authors have correlated this disease based
on symptomatology with various diseases and conditions told in our science. Though
they could not seemed it correlating exactly to that of essential hypertension, with few
signs and symptoms they have tried to correlate it. Some authors have just translated the
term essential hypertension to some terminologies.

8
SHAREERAM:
ANATOMY OF HEART:
The word hridaya explains and signifies only the functional aspect of an organ.
According to “shatapada brahmana the word hridaya is made up of three dhatus Hri,Da
and Ya. These dhatus by the combination of the pratyaya and adesha, forms the dhatus as
Hrit, Dana and Ayana.
The dhatu Hrit gives the meaning of Harana, Apatirite i.e.,to take or to receive.
The dhatu ‘Dana’ gives the meaning of Tyage, palane, chedane i.e., to give or to eject or
to nourish. The dhatu ayana having the paribhasha of kayam gives the meaning of Gati,
chalana or movement.
The word “hridaya” has been attributed to mainly two organs.Namely Mashtishka
or shirohridaya and hridaya i.e., Uro hridaya. Generally yogis attribute the word hridaya
to Mashtishka or brain and the physicians or Vaidyas denote the word hridaya to
urohridaya or Muscular heart.
In classics the anatomy and physiology of hridaya is not explained under one
heading or at one place. We get lot of quotations and similies based on which we should
understand the anatomy and physiology of heart.
Hridaya is considered as one of the koshtanga. It is situated in vaksha pradesha in
between the two stanas 1. It formed by sleshma and rakta2 having the shape of inverted
lotus3 and according to arunadatta it is made up of mamsapeshi and rakta.4 It measures
two angula according to chakrapani and four angula according to sushritha.
Hridaya is the mula of pranavaha and rasavaha srotas5. It is the seat of manas and
6
para and apara ojus . Hridaya is the prabhava sthana of dashadamanis which spreads all
7
over the body and which carries rasa, ojus and does tarpana karma . According to
palakapya from hridaya siras arise and spreads all over the body justlike a network and
like all rivers join ocean in the same fashion all siras opens into hridaya8. Hridaya
continuous to work whether the person is in jagrutavasta or swapatavasta9.

9
Relation of Hridaya with Doshas:

Hridaya is related with all the three doshas. Among vata, it is related with
udanavayu, prana vayu and vyana vayu. Among pitta, it is related with sadhaka pitta and
pachaka pitta and among kapha it is related with avalambhaka kapha.
Hridaya and udana vayu

Charaka and Vagbhata have mentioned the uras as the sthana of udana vayu10.
This indicated that it is related to hridaya also. When we look at the functions of udana
vayu, the functions like prayatna(endeavour or effort),urja(enthusiasm)and
11
bala(strength) , with respect to hridaya, we can think of the conductive system of the
heart i.e., udana vayu by the functions like prayatna and bala initiates and helps in the
conduction of the cardiac impulses in the heart.
Hridaya and prana vayu

According to Charaka and Vagbhara prana vayu is situated in shiras 12, and
13
according to Sharangadhara it is situated in hridaya .Vagbhata states that pranavata
maintains the activities of hridaya (heart and circulatory system) and supports or does
14
dharana of dhamanis(probably the vasomotor functions) .Looking to the above
description it can be said that pranavata situated in murdha sends impulses to hridaya,
there by governing the sympathetic and parasympathetic actions/functions.
Hridaya and Vyana vayu

15 16
Vyana vata is situated in hridaya , and it pervades swiftly throughout the body .
17
Vyana vayu is responsible for circulation of Rasa (rasadhatu) through out the body ,by
18
the regular contraction and relaxation of the heart . Sushrutha has also mentioned asruk
sravana to be one of the functions of vyana vayu19.Vagvhata concised all functions of
vyana vata by the statement that all the actions or movements of the body are conducted
by vyana vata20.
In Naadi gnynam it is mentioned that the rhythmic tendency of the heart is
responsible for continuous contraction and dilation of the hridaya and which is the
inherent tendency and capacity of hridaya. Enen Charaka has mentioned that vyana vayu

10
is responsible for the continuous flow of rasadhatu to all parts of the body through out the
life by using the words like ajasram and sada21.
Hridaya, Sadhaka pitta and Manas

22
Sadhaka pitta is situated in hridaya , and it is responsible for achievement of
buddhi, medha, abhimana, utsaha and abhipretartah. From this it is understood that, it is
essentially connected with some of the higher mental faculties and emotional states. The
concept of sadhaka pitta therefore, encompasses psycho-physiological actions. It is also
seen that hridaya is the adhisthana of manas 23. Acharya Charaka while mentioning
measures to protect hridaya and oja says to void the things that produces dukh to the
manas24.Even in unmanda chikitsa adhyaya also acharya charaka mentions about
manovaha srotas. Chakrapani commenting on it says the dhamani’s that orginate from
hridaya or the dhamani’ that are related to hridaya desha, are to be taken as manovaha
25
srotas . From all these it is clear that hridaya, sadhaka pitta and manas are related to each
other and the vitiation of one causes the vitiation of other.
Hridaya and Avalambaka Kapha

Avalambaka kapha is situated in uras 26.It does avalambana of hridaya i.e., with
the help of rasa it gives bala to hridaya. In other way it does tarpana and kledana of
hridaya and there by helping it to function properly.
Relation of Hridaya with Ojas

In shareera ojas has been classified in to two types, i.e., para ojus and apara ojus.
Para ojus is situated in hridaya27. It is asta bindu in pramana and it is said to be uttama
pranayatana (most important vital part). Even, if little of it is destroyed the body cannot
exist. Aprara ojus is situated in hridaya and dhamani and circulates all over the body. It is
ardhanjali in pramana and the deficiency of this ojus does not cause death but diseases
like prameha are likely to set in.
Looking to all these above references we cannot get a clear cut picture of anatomy
and physiology of heart. But it gives a clear idea that, the hridaya that is described is

11
nothing but the muscular heart or cardia. Even the classical quotations given for hridaya
almost fulfil the modern description that has been given for heart.
Heart is a conical, hollow muscular organ, situated in middle mediastinum. It is

enclosed within the pericardium. The heart is placed obliquely behind the body of the
rd
sternum and adjoining parts of the costal cartilages. So that 1/3 of it lies to the right.
rd
2/3 to the left of the median plane. The direction of blood flow, from atria to the
ventricles is downwards, forwards and to the left. The heart measures about 12X9 cm
(5X3 or 3 ½ inches) and weighs about 300gm in males, 250gm in females.
External features:
The human heart has four chambers. These are right and left atria and the right
and left ventricles. The atria lie above and behind the ventricles. On the surface of the
heart they are separated from the ventricles by an atrioventricular groove.
The atria are separated from each other by an interatrial groove. The ventricles are
separated from each other by an interventricular groove. This is subdivided into anterior
and posterior parts. The upper part of each atrium has an appendage called the auricle.
The heart has an apex directed downwards, forwards and to the left; a base (or posterior

12
surface) directed backwards, and anterior, inferior and left surfaces. The surfaces are
demarcated by upper, lower, right and left borders.
The heart is supplied by two coronary arteries, arising from the ascending aorta,
both arteries run in the coronary sulcus. The venous blood is drained by great cardiac
vein, the middle cardiac vein, and the small cardiac veins. The posterior vein of the left
ventricle, the oblique vein of the left atrium, the right marginal vein, the anterior cardiac
veins and the venae cordis minimae. All these except last two drain into the coronary
sinus which opens into the right atrium. The anterior cardiac veins and venae cordis
minimae open directly into the right atrium.
Parasympathetic nerves reach via the vagus. These are cardioinhibitory; on

stimulation they slow down the heart rate. Sympathetic nerves are derived from the upper
3.5 thorasic segments of the spinal cord. These are cardio acceleratory and on stimulation
they increase the heart rate, and also dilate the coronary arteries. Both parasympathetic
and symnpathetic nerves from the superficial and deep cardiac plexus, the branches of
which run along the coronary arteries to reach the myocardium.
REFERENCES:
1. Sus.sam.Sha-6/25
2. Susrita sam.Shari-4/31
3. Sus.sam.Sha-4/32
4. Asta.hri.Sutra-12/15. Arunadatta comment.
5. Cha.sam.Vima-5/
6. Cha.sam.Sutra-30/7
7. Asta.hri.Shar-3/15; Cha.sam.Sutra-30/
8. Paalakapya-16/41.
9. Sus.sam.Shari-4/32.
10. Cha.sam.Chi-28/7; Asta.sam.Sutra-20/4; Asta.Hri.Sutra-12/5
11. Cha.sam.Chi-28/7

13
12. Cha.sam.Chi-28/6; Asta.Hri.Su-12/4

13. Sharanga.Purva khanda-5/27,28 Adhamalla tika
14. Asta.Hri.Su-12/4,5;Asta.San.sutra-20/4
15. Asta.San.Su-20/4;Asta.Hri.Su-2/6
16. Cha.sam.Chi-28/9; Susritha sam.Nidana-1/17
17. Cha.sam.Chi-28/9; Susritha sam.Nid-1/17-18
18. Susritha sam.Sutra-15/3
19. Susritha sam.Nidana-1
20. Asta.Hri.Sutra-12/7
21. Cha sam.Chi-15/36
22. Asta.sam.Sutra-20/5;Asta.Hri.Sutra-12/11;Susritha sam. Sutra-21
23. Cha.sam. Sutra-30/4;Susritha sam.Sharira-4/31;Asta.sam.Su-12/15
25. Cha.sam.Chi-9/5.Cha.sam.Indriya-5/41
26. Astanga hridaya Sutra-12/15-16;Sushrita samhita Sutra-21/13
27. Cha.Sam,Sutra-30/7

14
ANATOMY OF BLOOD VESSELS:

The concept of blood vessels in our science has not been cleared till today. It has
been discussed under different headings by different acharyas.
While dealing about the blood vessels or raktavahinis the three terms that are used
are siras, dhamanis and srotas. These three are used with different meanings depending
on the context at different places.
Dalhana in Dhamanivyakharana adhyaya has described regarding sira, dhamani
and srotas elaborately. He has differentiated these then based on four pramanas,i.e.,
lakshana,mula,karma and agama. Dalhana ginving the reason for these three being read
together says though they are differentials yet have similarity in vahanakarma.
Different acharyas have given their opinion regarding these sira, dhamani and
srotas.
A Bird view on views and considerations of different acharyas on sira,dhamani

and srotas.
SIRA DHAMANI SROTAS
 Definition:
“Saranaat sirah1” “Dhmand dhamanyah2” “Sravanath srotamsi 3”
 Chakrapani,gangadh  Chakrapani,gangadh  Chakrapani,gangadh
ara,gananathsen’s ara,gananathsen’s ara,gananathsen’s
Opinion gives in favour of Opinion gives in favour of Opinion gives in favour of
vein. artery. capillaries.
 Asudda raktavahinis  Shudda raktavahinis  It has paryayas like
are considered as are considered as sira,dhamani,rasaya
sira and canbe dhamani and canbe na,nadi,pantha,marg
referred as referred as a etc.,
vein(atharvaveda) artery(atharvaveda)
 Pittavaha siras canbe  The word dhamani
considered as vein4 has been used with
 The word sira has the meaning of

15
been used with the jnyanatantuvu8.

meaning of  At parishad
5
kandara . shabdartha it was
 The word sira has concluded that
been used with the dhamani canbe
meaning of considered as artery,
dhamani6. nerve or vein or any
 The word sira vessel in the body.
denotes vein, artery  The word dhamani
7
and lymphatics . has been used with
the meaning of
9
rasavahini .
 The word dhamani
has been used with
the meaning of
sira10.
When we conseder all these references and considerations it is very difficult ot

come to a conclusion,whether sira could be considered as artery or dhamani could be
considered.
Acharya charaka is more of the opinion of considering dhamani to be as artery,
while sushritha considers rohini sira or asrigvaha sira as the artery. Even the parishad that
was conducted on shabdartha could not conclude on this controversy.
The whole circulatory system from the finest capillaries upto and including the
heart is lived by a smooth, continuous single layered endothelium. The walls of all
vessels except capillaries and sinusoids are formed by three analogous zones (coates)
from inside outwards the tinuca intima, tunica media and tunica adventitia. These coats
confer on the vessels a number of important properties, including an endothelial lining
low in friction and connective tissue components able to withstand longitudinal and
circumferential stresses due to prevailing blood pressures.

16
DIFFERENCE BETWEEN ARTERY &VEIN
The smallest arteries terminate in muscular arterioles 100-50um in

diameter,which branch into terminal arterioles less than 50um in diameter. Metaarterioles
are branches of terminal arterioles,10-15um,where they open into the capillary bed. They
are surrounded by a strong circular layer of non striated myocytes forming precapillary
sphicters,which effect the final control of blood flow through the capillaries. Precapillary
sphincters have been seen to open and close periodically with a cycle of 2-8 seconds.

17
REFERENCES:
1. cha.sam.Sutra-30/12. chakrapani comment.
2. cha.sam.Sutra-30/12. chakrapani comment
3. cha.sam.Sutra-30/12. chakrapani comment
4. Susrita sam.Sha-7/18
5. Sus.sam.Nidana-1/82
6. Sus.sam.Sha-7/14
7. Cha.sam.Chi-12/8
8. Sus.sam.Nidana-1/51,85
9. Sus.sam.Sha-9/12
10. Sus.sam.Sha-4/65.
PHYSIOLOGY OF BLOOD CIRCULATION:

Hridaya is the srotolula of rasavaha and pranavaha srotas1. It is responsible for
rasa samvahana in the body.
The ahara rasa that is formed is brought to hridaya by samana vayu and this as it
enters the hridaya at is considered as rasadathu. Now with the help of vyana vayu and
udana vayu the sankocha and vikasa i.e., the praspandana of hridaya starts. This function
of it can be correlated to the conductive system of the heart. Here sankocha can be
considered as systole and vikasa can be considered as diastole. Pranavata maintains the
actions of hridaya and does dharana of dhamanies. This indicates that it governs the
vasomotor functions. Once the sankocha takes place the rasa moves into dasha dhamani2
and proceeds further. Here by prasarana akunchana karma and as per kedarakulya nyaya.
The rasa moves to all parts of the body and nourishes the whole body. This function is
3
carried out continuously throughout the life .Even Bhela explains that rasa samvahana
takes place through siradhamani, which are spread all over the body and owes their origin
and insertion to hridaya. Sharangadhara while explaining rasa samvahana explains that
rasa, rakta, oja, sneha are carried from hridaya to all parts of the body and does tarpana
karma. Avalambaka kapha gives bala to hridaya to carryout these functions.

18
Regarding rasa samvahana acarya sushritha gives a simily i.e.,”Shabdharchi

jalasantanavat 4”.This indicated that rasa moves in all directions. Dalhana commenting on
it says, Urdhwagamitwa of rasa occurs like archi, Adhogamitwa of rasa like jala and
Tiryakgamitwa of rasa lika shabdha.
Again this rasa is brought back to the hridaya by vyana vayu.Samana vayu and
hridaya vikasana takes place followed by sankocha and rasa moving towards sarva
sharira. This cycle continuous and acharya charaka uses the word ajasra to denote
continuous function of hridaya in circulation of rasa5.
The activity of the organs of the circulatory system that is of the heart and blood
vessels ensures a constant flow of blood in the organism. Because of its movement, the
blood can perform numerous transport functions, in particular, supplying oxygen and
nutrients to the tissues and removing substances formed as the result of metabolism.
The movement of blood in the organism follows a complicated course known as
the systemic or greater circulation and the pulmonary or lesser. The systemic circulation
starts at the left ventricle of the heart, passes to the aorta, to the arteries, originating from
it and to all their branches, there to the arterioles, capillaries and the veins of the whole
body and finally to the two venaecavae which enter the right atrium. The pulmonary
circulation begins from the right ventricle, continuous along the pulmonary artery and all
its branches, then along the pulmonary arterioles, capillaries and veins and terminates in
the pulmonary veins which empty into the left atrium.
The flow of blood in the vessels is due to the work of the heart. Contraction of the
ventricular myocardium ejects blood under pressure from the heart into the aorta and
pulmonary arteries. The movement of the blood further along the vessels and its return to
the heart is conditioned by its pressure in the large arteries being higher than in the small
arteries. The pressure in the latter is being higher than in veins and atria. In this way there
is difference in pressure all along the blood stream. That determines its circulation in the
vascular system. Blood flowing from the vessels of higher pressure to those with the
lower pressure. The gradual drop in the pressure along the blood stream (from the arteries
to the capillaries and veins) is brought about by the fact that the energy imported by the
heart is utilized to overcome the resistance of the vessels to the movement of the fluid

19
arising from friction between the fluid particles and the vascular wall and between the
particles themselves.
The function of the heart is rhythmic pumping of blood that it receives from the
veins into the arteries. It is performed by alternate rhythmic contraction and relaxation of
the muscular fibres that forms the walls of the atria and ventricles contraction of the
myocardium of these chambers is known as their systole and relaxation as their diastole.
In normal physiological conditions systole and diastole occurs in a definite
coordination and constitute the cardiac cycle. Each cycle is considered to start with the
atrial systole. The contraction begins as a wave in that part of the right atrium where the
orifices of the venecavae are and then involves both atria which have a common
musculature with a cardiac rhythm of 75 contractions per minute; an atrial (auricular)
systole lasts 0.1 second. As it ends, the ventricular systole begins the atria then being in a
state of diastole which lasts 0.7 second. The contraction of the two ventricles occurs
simultaneously, and their systole persists for about 0.3second. After that ventricular
diastole begins and lasts about 0.5 second. One tenth second before the end of the
ventricular diastole a new atrial systole occurs, and a new cycle of cardiac activity begins.
REFERENCES:
1. Cha.sam.Vimana-5
2. Cha.sam.Chi-15/30
3. Cha.sa.Chi.15/36
4. Sus.sam,Nidana-14/
5. Cha.sam.Chi-15/36.

20
REGULATION OF BLOOD PRESSURE:

Physiologically the magnitude of the arterial pressure depends on two
fundamental hemodynamic variables; cardiac output and total peripheral resistance. In
other words, the arterial blood pressure is a product of cardiac out put and peripheral
vascular resistance.
Illustration showing the blood pressure regulation:
Humoral factors
Blood volume Constrictors Dilators.
-Sodium -Angiotensin II
-Prostaglandins
-Mineralo corticoids -Catacholamines -Kinins
*
-Atriopeptine -Thromboxane -NO/EDRF
-Leukotriens
-Endothelin
BP=Cardiac Out put X Peripheral Resistance
Neural factors Local factors

Cardiac factors Constrictors Dilators -Autoregulation.
-Heart rate -αadrenergic -βadrebergic -Ion(HP,Hypoxia)
-Contractility
*Endothelin derived relaxing factor.

21
The blood pressure can be raised by increased peripheral resistance and by

increased cardiac output.
The cardiac output depends upon the heart rate, its contractibility and the blood
volume. The blood pressure can be raised by an increase in the volume of fluid
absorption of water and water retaining sodium from the intestine in to the vascular
system or and increased production of the adrenocortical hormonal aldosterone, which
blocks the excretion of sodium and water into the urine.
It appears that most patients with established hypertension have abnormal cardiac
output and blood pressure is mainly sustained by increased peripheral vascular resistance.
The peripheral vascular resistance is determined by the arteriolar lumen, which
may expand or contract depending on the state of muscular cells in the vessel wall. This
is known as local vascular tone. Normal vascular tone depends on the competition
between vasoconstricting influences and vasodilators. Peripheral resistance depends on
the size of the lumen of some vessels. A decrease in the inner (lumen) diameter will raise
the blood pressure. The decrease in the lumen could be brought about by an anatomical
thickening of vessel walls (eg, intima thickening of arteries), by their mechanical
compression from outside or most commonly by their active muscular contraction which
cab be induced by a variety of vasoconstrictor mediators. The common vasoconstricting
mediators are epinephrine, norepinephrine and rennin-activated angiotensin II. The other
recently described vasoconstrictors include endothelinI, thromboxane and leucotrienes.
Resistance vessels also exhibit auto regulation, a process by which increased blood flow
to such vessels induces vasoconstriction, an adaptive mechanism that protects against
hyperperfusion of tissues. The vasodilators include kinins, prostagandins and nitric oxide.
Certain metabolic products such as lactic acid, hydrogen ions, adenosine and hypoxia can
also function as local vasodilators.
Recently it has been discovered that haemoglobin plays an important role in
regulation of blood pressure. In the body tissues, haemoglobin releases oxygen and super
nitric oxide (SNO) and picks up carbon dioxide. The released SNO causes vasodilatation.
At the tissue level haemoglobin also picks up excess nitricoxide (NO), which tends to
cause vasoconstriction. Thus haemoglobin helps in regulating the blood pressure by
adjusting the amounts of SNO and NO to which blood vessels are exposed. This newly

22
appreciated role of haemoglobin bay influence development of drugs to treat

hypertension.
Further the arteriolar smooth muscle contraction can be increased by increased
sympathetic tone and also by increased sodium load and extra cellular fluid load.
The kidneys play an important role in the blood pressure regulation, and there is
considerable evidence that renal dysfunction is essential for the development and
maintenance of both essential and secondary hypertension.
The kidney influences both peripheral resistance and sodium homeostasis, and the
rennin-angiotensin system appears central to these influences. Rennin elaborated by the
juxtaglomerular cells of the kidney transforms plasma angiotensinogen to angiotensinI,
and the latter is converted to angiotensin II by angiotensin converting
enzyme(ACE).angtiotensin II alters blood pressure by increasing both peripheral
resistance and blood volume. The former effect is achieved largely by it’s ability tocause
vasoconstriction through indirect action on vascular smooth muscle, the latter by
stimulation of aldosterone secretion, which increases distal tubular re absorption of
sodium and thus of water.

23
Illustration showing the role of Renin-Angiotensin system:
JG
Renin
Renin substrate
Angiotensin I
Angiotensin II
Vaso constriction Increased Aldosterone systhesis
Sodium retention
BLOOD PRESSURE

24
 The kidney produces a variety of vasodepressor or antihypertensive substances

that presumably counter balance the vasopressin effects of angiotensin. these
include the prostaglandins, a urinary kallikrein-kinin system, platelet-activating
factor, and nitric oxide.
 When blood volume is reduced, the glomerular filtration rate falls(GFR), this ,in
turn, leads to increased reabsorption of sodium by proximal tubules in an attempt
to conserve sodium and expand blood volume.
 GFR-independent natriuretic factors, including atrial natriureteic factor(ANF),a
peptide secreted by heart atria in response to volume expansion, inhibit sodium
reabsorption in distal tubules and cause vasodilation. Abnormalities in these renal
mechanisms are implicated in the pathogenesis of secondary hypertension in a
varietyu of renal diseases, but they also play an important role in essential
hypertension.

25
Measurement of blood pressure:

The measurement of blood pressure should be done correctly. Blood pressure
varies from moment tomoment, respiration, emotion, exercise, meals, alchol, tobacco,
bladder distention, temperature and pain. It is also influenced by circadian rhythm, age
and race.
Shortly after “scopine-riva rocci” invented the sphygmomanometer the Russian
surgeon “korotkoff” suggested that by placing a stethoscope over the brachial artery at
the anticubitalfossa distal to the riva rocci cuff, sounds could be heard. The origin of
these sounds is still not clear, vibratory how phenomenon is probably responsible.
Blood pressure can be measured directly or indirectly. There are three common
devices used for the indirect measurement of blood pressure namely.
1. Sphygmomanometer, either mercury column or aneroid.
2. Electronic devices.
` 3. Automated ambulatory blood pressure devices.
However mercury sphygmomanometer remains the gold standard for
measurement.
The mercury column:
The mercury meniscus should be at zero.
The sphygmomanometer cuff:
Both the length and width of the inflatable bladder are critical. The bladder
(length) should encircle at least 80%of their circumference of the arm whilst the width
should at least b 40% of the circumference.
The sphygmomanometer inflation deflation device:
It is important to ensure that inflation deflation device functions properly.
The following may indicate malfunction of device.
*Failure to achieve a pressure of 40 mmof Hg above the estimated systolic blood pressure
or 200 mmoHg after 3-5 seconds of rapid inflation.
*The inability of the equipment of deflates slowly when the controlling release value is
opened at 2-3 mmofHg per second or at each pulse beat.

26
Auscultatory measurement of systolic and diastolic pressures:

The following technique is recommended for the measurement of blood pressure
using a sphygmomanometer:
Patient should be adequately rested seated with their arms supported and at heart
level. They should not have smoked or ingested coffee within 30 minutes of
measurement.
The systolic blood pressure should be estimated initially by palpation while

palpating the brachial/radial artery, the cuff is inflated until such time the pulse is no
longer palpable. The cuff should then be inflated to a further 30mmofHg. The cuff is then
slowly deflated and the pressure at which the pulse is palpable is estimated systolic blood
pressure.
The bladder is then inflated to 30 mmofHg above the previously estimated

systolic blood pressure and the pressure reduced at 2-3 mmofHg per second or pulse beat.
Here the auscultatory korotkoff sounds are classified under five phases.
Phase I:
The first appearance of faint clear tapping sounds (thuds) which gradually
increase in intensity. This gives the systolic blood pressure. This technique is important
because phase I sounds sometimes disappears as pressure is reduced and reappear at a
lover level (the auscultatory gap) resulting in under estimation of the systolic blood
pressure.
Phase II:
The softening of the sounds which may become Swissing or blowing.

27
Phase III:
The return of sharper softer sounds, which become crisper, but new fully regain
the intensity of phase I sounds. Neither phase II nor phase III has any known clinical
significance.
Phase IV:
Distinct abrupt muffling of sounds, which become soft and blowing.
Phase V:
The point at which all sounds disappear completely. This should be taken as the
diastolic reading.
In some groups eg: pregnant woman, anemia or elderly patents the sounds may
continue until the zero point. In such instances the muffling of the respective sounds
(korotkoff phase IV) is taken as the diastolic pressure. The point of muffling is usually
higher than the true arterial blood pressure. If korotkoff phase IV is used this should be
clearly recorded.
The blood pressure should be measured in both arms. It the difference in blood
pressure between the two arms is >20/10 mmofHg, then may be an anomaly which
requires further evaluation.
The blood pressure should be taken both lying and at least one minute after
standing to detect any postural drop.

28
Showing the phases of korotkoff sounds:

29
NIRUKTHI:
The word “Bhrama” dathu adding ghai pratyaya bhrama shabdha is derived. It is
pumlinga shabdha.
PARIBHASHA:
“Chakravath bhramato gatram bhoomou patati sarvadaa
Bhrama roga iti gneyo”
Bhrama defined as reeling sensation experienced by a patient forcing him to

losing his balance there by falling on ground.
Vertigo definition:(stedman’s dictionary)

A sensation of irregular or whisling motion either of oneself (subjective vertigo)
or of external objects (objective vertigo).
Implies a definite sensation of rotation of the subject or of objects about the
subject in any plane.
DEFINITION:
The definition of hypertension has been revised by various authorities including
the world health organization/international society of hypertension(WHO/ISH) and the
American joint national committee on the detection, evaluation and treatment of high
blood pressure (JNC-VII report) and they define as any blood pressure reading that
Consistently stays at 140/90 or higher is considered higher blood pressure.
Desirable blood pressure for healthy adult is 120 Systolic Blood Pressure/80
Diastolic Blood Pressure.
Hypertension is the level of blood pressure at which the benefits of treatment
Outweigh its costs and hazards.
Definition of Essential hypertension:

Hypertension is said to be essential when there is no obvious precipitating cause.

30
Traditionally the diagnostic level of essential hypertension is applied only to those cases
of hypertension where investigation has failed to reveal any renal, endocrine or other
primary cause. Unfortunately there is no clinical or laboratory tests which can provide a
quick positive diagnosis of essential hypertension and exclude other secondary types of
hypertension but, essential hypertension is a clinical entity in itself, although its
pathogenesis is unknown.
In more than 95%of people who have high blood pressure the underlying cause
is listed as essential hypertension. Thus, patients with arterial hypertension and no
definable cause are said to have primary, essential or idiopathic hypertension.
In recent times many Ayurvedic scholars have tried to give an appropriate term
to hypertension in Ayurveda. Following are the different correlations and different
terminologies suggested by various scholars-
 Raktagata vata :Prof. Yadunandana Upadhyaya. And

Shri Sudarshana shatri; Bhupendra pal(varanasi)
 Siragata vata :Prof.G.N.Chaturvedi and Dr.K.N.Shastri
 Roudira mada :Acharya vishwanath dwivedi
 Dhamani pratichaya : Vaidya A.D.Athawale; Vaidya Ranajit Rai Desai
 Rakta vata :Prof.Yadunandana upadhyaya and
Sri Sudarshana shastri; Dr.sharma(Puri)
 Dhamani upalepa :Prof.G.N.Chaturvedi and Dr.K.N.Shastri
 Mada,Murcha,Sanyasa :Kaviraj kumud ranjan roy
 Vyana bala vaishamya :Vaidya brihaspati Triguna
 Dhamani prapoornata :Vaidya G.N.Saraswathi
 Uccha rakta nipeedana :Acharya vidhyadar shukla
 Uccha rakta bhara : Dr.Patak U.C.(Jaipur)
 Rakta sammardhana :Prof.G.N.Chaturvedi
 Rasa bhara :Vaidya T.S.Mishra
 Avritha vata roga :Vaidya R.K.Sharma
 Rakta sampeedana :Vaidya S.P.Panday

31
 Rakta vega vriddi :Vaidya V.B.Athavale

 Sleshmavrita vyana :Dr.Gupta H.C.(varanasi)
 Raktatimardam :Dr.John K.George
 Uccha rakta chapa :Prof.Madan gopal sharma and
Dr.Ajay kumar shrma
Prevalence:
The prevalence of hypertension depends on both the racial composition of the
population studied and the criteria used to define the condition. In a elite suburban
population like that in the Framingham study merely 1/5th of individuals have high blood
pressure’s >160/95, while almost one half have pressures >140/90. An even higher
prevalence has been documented in the nonwhite population.
In females, the prevalence is closely related to age, with a substantial increasing
occurring after age 50. This increase presumably related to the hormonal changes of
menopause, although the mechanism is not clear.
Prevalence of various forms of hypertension in the general population and in
specialized referral clinics.
Diagnosis General population in% Speciality clinic in%

A.Essential hypertension. 92-94 65-85
B.Renal hypertension
i)parenchyma 2-3 4-5
ii)Reno vascular 1-2 4-16
C.Endocrinal hypertension
i)Primary aldosteronism 0.3 0.5-12
ii)Pheochromocytoma <0.1 0.2
iii)Oralcontraceptive pill 0.5-1 1-2
induced hypertension
D.Miscellaneous 0.2 1
Some of the other forms of hypertension are :

32
*Borderline systolic hypertension: The diastolic blood pressure is normal and systolic
blood pressure is between 140 and 159 mmofHg.
*Isolated systolic hypertension: The systolic blood pressure is 160 mmofHg and above
and fluctuates from time to time high in the morning and low at night.
*Labile(transient) hypertension: The patient is hypertensive at one time and

normotensive at another time.
*Benign hypertension: Is moderate elevation of blood pressure and the rise is slow over
the years.
*Malignant hypertension: Hypertension is associated with complications like papilla

edema, retinal exudates haemorrhage. No absolute blood pressure level can be assigned
for this condition. However these patients usually have blood pressure around 200/140
mmofHg.
*Accelerated hypertension: Denotes a recent rise in blood pressure with retinal damage,
but without an papilla edema.
*White coat hypertension: Is a condition in which blood pressure is elevated in the

presence of a medical person but falls when the subject leaves the medical environment.

33
NIDANAM:
Nidana panchaka consists of nidana, purvarupa, rupa, upashayanupashaya and

samprapthi.
Nidana is the hetu for the disease which is the causative and aggravating
factor.Nidana may be vyadi janaka and vyadhi bodhaka1.
“Bhrama” is the symptom in many diseases. It is not mentioned as an individual

2
disease. Which is manifested due to prakopa of vata,pitta and rajo guna .
Every disease is due to tridosha vaishamyata only3. In this disease individual dosha
prakopa karanas can aggravate the doshas and causes the disease.
Vata prakopa karanas can aggravate the vata dosha in the body, pitta prakopa
karanas can cause the pittadosha prakopa and causes bhrama which is the cause for fall
4
on the ground .
For the understanding purposes nidana can be divided into four sub divisions they
are i) Aharaja
ii) Viharaja
iii) Panchakarmajanya
iv) Anyaja
VATA PRAKOPAKA NIDANA:

a) Aharaja:
1. Teekshana, laghu, sheeta guna aharas can cause the vata prakopa 5 .
2. Anashana, Adyashana, Vishamashana, Vishamopacharam, Viruddahara sevana
can also cause vata prakopa6.
3.Sushkashaka,Vallura,Varakoddalaka,,Koradoosha,Shyamaka.Neevara,Mudgara,
7
Masura,Adhaki,Harenu,Kalaya Nishpava .

34
b) Viharaja:
1. Ativyayama, Vegasandharana, Vyavaya, Jagarana, Bharaharana,
Gajaturagaradha padhaticharya 8, Prapatana, Bhagnam.
c) Panchkarmajanya:
1. Vamana, Virechana, Shirovirechana atiyogas 9

2. Doshatisravanam
3. Raktati sravanam.
d) Anyaja:
1. Abhighata, Unmada, Shoka, Vishama sharirasya.
2. Chinta, Rogatikarshana.
3. Marma gatam10
4. Gajashva shigrayanam
5. Atitrasaka11
6. Kama shoka bhayam leads to vata prakopa12.
PITTA PRAKOPA KARANAS:

a) Aharaja:
1. Ushna, amla, lavana, kshara, katurasa adhika bhojana can cause pitta prakopa.
2. Ajirna bhojana, Atisevitha bhojana can cause pitta aggravation 13.
3. Tila, Atasi, Dadhi, Sura, Sukta, Aranaala and Kuluttha.
4. Dushtannam
5. Vidahi padartha sevana
14
6. Ahara vidahikala
7. Ksharam15.

35
b) Viharaja:
1. Teekshan atapa sevana, Agni santapa can cause pitta prakopa.
2. Shrama, Krodham16.
c) Pancha karmajanya:
17
1. Vamana, Virechana and Nasyakarma atiyogam .
2. Doshati sravanam.
3. Raktati sravanam.
d) Anyaja:
1. S harad ritu and varsha ritu(Pitta sanchaya)

2. Madyahnam
3. Stri prasangam
4. Bhayam18
5. Krodham19
6. Ashudda lohas20.

36
NIDANA REFERENCES:
1. Cha.samhita nidana.1/7 –chakra pani teeka

2. Madhava nidana-17/19
3. Cha. Samhita Su.-19/37
4. Madhava nidana-17/20
5. Cha.samhita Nidana-11/9
6. Cha.samhita Su.-26/86-87
7. Susrutha samhita Su.-21/19
8. Susrutha samhita Su.-21/19
9. Cha.samhita chi.-28/15-18
10. Cha.Samhita Su.21/27
11. Chikitsa kalika
12. Cha.sam.chi.-3/
13. Cha.sam.nid.-1/22
14. Susrutha sam. Su.-21/11 Ashtanga sangraha nidana-1/27
15. Astanga sangraha Nidana-17
16. Cha.Sam. Nidana-1/22
17. Cha.sam.Chi.-28/15-18
18. Susrutha samhita Sutra-21
19. Cha.sam.Chi.-3/
20. Astanga sangraha Su.-9/57.

37
ETIOLOGY:
Essential hypertension means that the cause of disease is not known; however in
recent years, experimental, epidemiological and therapeutic evidence seems to indicate
that essential hypertension is due to one or combination of etiological factors.
Its diverse hemodynamic and pathophysiologic derangements are unlikely to

result from a single cause. Heredity is a predisposing factor, but the exact mechanism is
unclear. Racial and environmental factors seem to act only in genetically susceptible
persons. So the factors responsible for the development of essential hypertension are-
1)Genetic factors:
The role of heredity in the etiology of essential hypertension has long been
suspected. The evidences in support are the familial aggregation, occurrence of
hypertension in twins, epidemiologic data, experimental animal studies and identification
of susceptibility gene (angiotensinogen gene).
Recent advances in genetic determination of human essential hypertension are

discussed by reviewing the candidate genes.
Acharya charaka while describing the genetic influence in disease says, at the
time conception, if the beeja (shukra or ovum), beeja (chrosome) or beeja bhaga
avaytava(genes) get vitiated, it is likely to travel in subsequent generations 1.
Dalhana has also commented that beeja dushti does not mean whole dushti, but
there may be a dushti of a part of beeja, that is the organ developing from that particular
part are also defective or abnormal2.while classifying the diseases, acarya sushritha has
mentioned “adibala pravritta vyadhi” and is said to originate due to deformity of raja or
3
veerya of the parents at the time of conception .

38
2)Racial and environmental factors:

Surveys in the U.S have revealed higher incidence of essential hypertension in
blacks than in whites. But in rural Africa hypertension is relatively rare, suggesting that
the high prevalence in the U.S is not because of the genetic tendency, rather, it might be
due to adaptation of western life style by American blacks.
There is a lot of controversy as to what are the important environmental factors.

One of the strongest bits of evidence showing that, the environment in which a person
lives affects his blood pressure.
3) Salt intake:
The environmental factor that has received the greatest attention is salt intake,
although not everyone with excessive salt intake develops hypertension, the cause of
special sensitivity to salt varies with primary aldosteronism, bilateral renal artery
stenosis, renal parenchymal disease etc.
Diets, which are high in sodium, are usually low in potassium. Potassium
supplements improve the effects of experimental hypertension, and found to lower blood
pressure of mild to moderate hypertensive. Potassium antagonizes the biological effects
of sodium and there by reduces blood pressure.
Excessive use lavana is described in charaka samhita as the cause of rakta vriddi
4
and leads to shonitaja roga . Since rakta dhatu is one of the important dushya in the
etiopathogenesis of hypertension, it is given more importance. The symptoms of
shonitaja roga are similar to this essential hypertension. Again charaka has told that
lavana should not be consumed in excess and for longer duration5.when excessively used,
it produces fatigue, lassitude and weakness of body6, which the symptoms are usually
found in patients of hypertension.
In ashtanga sangraha, lavana is said to increase shareera kleda leading to

increased cardiac output, one of the responsible factor in regulation of blood pressure.

39
4)Obesity:
There is however an important confounding factor to be taken into account that
there is a strong link between excess body fat, blood pressure levels and prevalence of
hypertension. As obesity contributes to go blood lipid abnormalities and impaired glucose
tolerance; it has particular significance as a factor underlying the increased prevalence of
coronary artery disease in hypertensive patients. For every 10%increase in weight a rise
of 6.5mmof Hg in systolic pressure was observed in Framingham study.
7
Sushrutha has mentioned medoroga leads to vata vikara . Commenting on above
verse Dalhana explained that vatavikara is produced due to medvrita marga. Apart from
this in astauninditiya adhyaya of charaka sutrasthana, acharya has described the
complications of sthoulya. Here the apakva medas when deposited in reasvaha srota, may
lead to dhamani pratichaya 8 (atherosclerosis), which is the main factor responsible for
hypertension.
5)Stress:
Acutely stressful stimuli certainly raise blood pressure and may be more causative
in subjects who have familial hypertension. Sustained or repeated emotional stress(anger,
frustration, envy, hatred, fear and worry) causes arteriolar contraction through an
outpouring of norepinephrine from the sympathetic vasomotor nerve endings and
epinephrine from the adrenalomedulla. It is probable that some of these persons have
inherited abnormalities of increased reactivity of the sympathetic vasomotor nerve
endings and epinephrine from the adrenal medulla. It is probable that some of these
persons have inherited abnormalities of increased reactivity of the sympathetic nerve-
endings to emotional sensory stress, and or increased reactivity of their arteriolar smooth
muscle to norepinephrine and epinephrine.
In some persons, the blood pressure increases due to the presence of the doctor
(white coat hypertension).this is possibly due to the temporary emotional stress. The over

40
activity of he sympathetic nervous system has an important part to play in the

pathogenesis of hypertension.
In ayurveda sthana of manas is said to be related to shira and hridaya, which are
in turn related to prana and vyana vayu respectively, which have influence over function
of maintaining the blood pressure. So aggrevated vata will initiate the process of
9
hypertension .
Acharya charaka while describing about srotas, has mentioned that rasavaha
srotas get deranged due to chinta or worries, which is the responsible srotas for rasarakta
sancharam.
Raja and tama are the doshas pertaining to the mind and the types of morbidity
10
caused by them are kama, krodha, lobha, moha, bhaya etc ., Acharya charaka has
advised to suppress these factors 11,because they tend to elevate raja and tama gunas
which cause manodushti. This obnoxious state of mana produces manovikara with
involvement of samjanavaha or manovaha srotas12. Further chakrapani commenting on
srotomula says, hridya and dashadhamani are the manovaha srotomula13. In this way the
arteries of the heart may get afflicted by these manovikara and therefore they also afflict
14 15
oja which is also ashrita of hridaya , and vitiation of vata and pitta , also takes place.
Hence it may be concluded that all the psychological factors directly (vitiated vata
with involvement of hridaya, oja and dhamanies) provoke vyana vata, which can produce
hypertensive state.
Urban populations have higher blood pressures than rural populations. Further
the adverse effects of urban living are confirmed by the rise of blood pressure in the rural
population migrating to cities. Crowding, air pollution and stress in cities may be
responsible for this happening.

41
6)Meals:
After meals the blood pressure is little higher.
7)Emotions:
Rage and panic raise the blood pressure, however, in exceptional panic, there may
be fainting attacks.
8)Sleep:
Sleep causes a fall of blood pressure. However, sleep associated with nightmare,
dreams may cause rise of blood pressure.
9)Exposure to cold:
It causes rise of blood pressure. This is due to hypothalamic stimulation. There is
cutaneous vasoconstriction leading to increased resistance to the blood flow and elevation
of blood pressure (cutaneous vasoconstriction causes conservation of heat within the
body).
10)Geographic factors:
Several studies have shown that high altitude residents have lower blood pressure.
Possible constituting factors include-
1) Lower peripheral resistrance due to increased capillarisation of tissues.
2) Hypoxia causing reduced thyroid activity and
3) Primitive conditions.
11)Physical activity:
Several population studies have suggested that individuals who undertake regular
physical exercise have lower blood pressures than sedentary individuals.

42
Regarding exercises, dynamic exercise raises blood pressure and isometric

exercise raises it a lot more. Despite this, there is good evidence that people who take
regular exercises are healthier and have lower blood pressures than those who take none.
In Ayurveda idle sitting is told to be one of the astamaha doshakarabhava16
While moderate normal exercise brings about the healthy state of body and mind.
Therefore, lack of physical exercise for prolonged period may result in agnimandya.
Hence produce apakva ama rasa, which deposits in vahinis and produce dhamaniupalepa
or pratichaya. On the other hand, over exercise leads to vata prakopa, leading to
aggravation of vataja vyadhi.
12)Trace metals:
It has been claimed that both cadmium and lead; which are environmental
pollutants, may cause high blood pressure. The main source of cadmium to the human
body is cigarette smoke. Conversely, however, there is fairly good evidence that blood
pressures are lower in areas where the drinking water is hard (i.e, has higher calcium
content). The mechanisms for this are unknown.
13)Socio-economic status:
Blood pressure is consistently higher in people from the lower socio-economic
classes. The poorer classes have however, concurrently higher average body weight,
greater consumption of alcohol and tobacco and more exposure to noise etc., while some
studies in India have indicated a higher prevalence of hypertension in the higher socio-
economic groups, a very large study in Mumbai found no difference between high and
low socio-economic groups. So higher or lower socio-economic status does not have
significant effect on blood pressure.
14)Age:
The younger the patient when hypertension is first noted, the greater is the
reduction in life expectancy, if the hypertension is left untreated.

43
Older people tend to have higher blood pressure than young people. Almost all
surveys show that blood pressure rises with age in both men and women. Studies have
demonstrate the two important trends; firstly, blood pressure rises with advancing age
and secondly, those individuals whose blood pressure starts at a higher level tend to
retain their place in the distribution of blood pressure and therefore, sustain a faster age-
related rise in pressure. Due to thickening of vessel wall, as increase in sub-endothelial
layer and the media, which increase collagen content, elastic fragmentation and
calcification.
In vriddavasta vata is the predominant dosha. 17 there is high predisposition to
develop vataja vikaras in the old age. Physiological aggravation of vata with it ruksha,
khara, daruna, sheeta gunas etc., may cause sankocha and kathinyata of the vessels.
15)Sex:
At all ages and in both whit and non-white populations, females with
hypertension fare better than males up to the age of 65,and the prevalence of
hypertension in pre menopausal females is substantially less than that in age matched
males or post menopausal women. Yet, compared with their normotensive counterparts,
females with hypertension run the same relative risk of a morbid cardiovascular event as
males do.
Regarding the less prevalence of hypertension in premenopausal females, the
possible explanation in ayurveda is that female body is purified every month because of
menopausal flow (in the context of prameha nidana).
16)Smoking:
Nicotine and carbon monoxide, two major products of tobacco combustion, are
both potent vasoconstrictors. Tobacco smoking has been reported to cause acute rise of
blood pressure, but whether prolonged smoking leads to sustained hypertension has not
been established. Several studies from the developed world have reported no relationship
between smoking and levels of blood pressure; some have even reported slightly lower

44
blood pressure amongst smoker’s .in the National study the percentage of smokers and
non-smokers was almost the same.
In Ayurveda, tobacco is derived from a plant Tamra (nicotiana tobacum), which
has the madaka effect and has property to aggravate pitta and rakta. It also causes
“bhrama” and mada. Apart from this, smoking causes rukshata in siras. Along with this
the deposition of nicotine causes narrowing of the lumen, thus vataprakopa and all
together resulting in to hypertension.
17)Alcohol intake:
Several studies have shown a strong and independent positive relationship
between alcohol intake and blood pressure. It has been estimated that about 10% of
hypertensives have alcohol-induced hypertension. The alcohol-hypertension relationship
still remains the subject of future research, particularly as no convincing mechanism can
yet be identified.
In Madatyaya chapter, acharya charaka has explained that, when madya is taken
in large quantity, it shall affect channels of rasa(rasavaha srotas)and by entering hridaya it
affect the dhatus situated in hridaya(rasa,oja,rakta). The gunas of alcohol like ushna,
teekshna, sukshma, vyavayi etc. are exactly opposite to the gunas of oja18,which also
provoke vata-pitta dosha. Destruction of oja would disrupt the normalcy of prana and
vyana vayu, sadhaka pitta and avalambaka kapha, which are the asritas of hridaya.
Charaka has also described pradusta, bahu (excessive), ushna, teekshna

madyapana and surapana as causative factors of shonita dushti. Further, It is the shelter
to moha, krodha, shoka and mrityu19 like wise madya affects dosha,dhatu,srotasadn
srotomula of rasavaha srotas(circulatory system) leading to hypertension 20.

45
References:
1. Cha.sam.sha-3/17
2. Sushritha sam. Shar-4/36
3. Sushritha sam. Sutra-24/5
5. Cha.sam.Vima-1/15
6. Cha.sam.Vima-1/18
7. Sushrita sam.sutra-15/32
8. Cha.sam.sutra-21/4; Cha.sam.sutra-20/17; Asta.sam.Sutra-20
9. Asta.hri.sutra-12/4
10. Cha.sam.vima-6/5
11. Cha.sam.sutra-7/27
12. Cha.sam.sutra-24/25 chakrapani comment
13. Cha.sam.Indriya-5/41
14. Sushrita sam.sutra-15/23
15. Cha.sam.chi-28/16-17; Sushrita sam sutra-21/20
16. Cha.sam. siddi-12/11
17. Astanga hri.sutra-1/8
18. Cha.sam.chi.24/30-31; Sushrita sam utta-47/3
19. Cha.sam.chi-24/5
20. Cha.sam.chi-24/35-36

46
PURVA RUPA:
Bhrama is a symptom which was mentioned in so many disorders.
Purva rupa is a symptom which describes or indicates the disease which is
appearing in the future1.
In some disorders the purvarupa may be seen in less quantity, further it may
increase when it reaches to rupavasta 2,3.
Purvarupa can be divided into two types4. They are
1. Samanya purva rupa
2. Vishishta purva rupa.
In samanya purvarupa it indicates the disease but not the doshik dominance. But
in Vishishta purva rupa it indicates the disease as well as the doshik dominance of the
disease5.Bhrama mentioned as a purvarupa in the following disorders.
S.no. Name of the disease Mentioned in

1 Jwaram Cha.samhita
2 Apasmaram Cha.Samhita
3 Arshassu Susrutha samhita
4 Rakta pitta Ashtanga hridaya
5 Arshassu Astanga hridaya
6 Grahani Ashtanga hridaya
7 Kushta Ashtanga hridaya
8 Jwara(pitta) Madhava nidana
9 Masurika Madhava nidana
PURVA RUPA REFERENCES:

1. Chakra datta commentary
2. Ashtanga sangraha Nidana-1/
3. Susrutha samhita Sutra.-21/
4. Madhu kosha comment
5. Madhu kosha comment.

47
RUPAM:
The collection of symptoms which can indicate the present disease is known as
1
rupam .
The symptoms of established disease are known as Rupas2.
The synonyms for the Rupam 3 are 1.Samstanam
2. Vyanjanem
3. Lingam
4. Lakshanam
5. Chihnam
6. Akriti
The rupas can be devided into 2 types4.
They are 1. Samanya rupa
2. Vishishta rupa.
Vishishta rupa can also call as “Pratyatma lakshanam”/ “Pratyatmika lakshanam”.
Bhrama as a rupa mentioned in so many diseases by various authors.
These are In Jwara chapter VP Jwara, Sheeta jwara, Raktagata jwara, Antarvega
jwara and Pachyamana jwara by Madhavakara5.Whereas Charaka mentioned in Vata
Jwara and Pitta jwaraonly6. But Sushritha was not mentioned in Jwara chapter. Vagbhata
mentioned in VK Jwara, Visha jwara and Abhichara jwara 7.
In other chapters the rupam bhrama mentioned as
Disease Author
8
1.Pittaja kasa Astanga hridaya nidana
9
2.Pittaja hridroga Astanga hridaya nidana
3.Vataja trishna10 Asta.Hri.Nidana
4.Vataja udavartha11 Madava nidana
5.Pittaja madatyayam 12,13 Asta.Hri.Nidana/Madava nidana
6.Vataja murcha14 Asta.Hri.Nidana
15
7.Pittaja chardi Madava nidana

48
8.Vataja arshas 16,17 Asta.Hri.Nidana/Madava nidana

9.Vata kundalika18 Asta.Hri.Nidana
19
10.Vata vidradi Asta.Hri.Nidana
11.Pittaja udaram/Sannipata udara 20,21 Asta.Hri.Nidana/Madava nidana
12.Pandu 22 Asta.Hri.Nidana
23
13.Halimakam Madava nidana
14.Pittaja shopha 24,25 Asta.Hri.Nidana/Madava nidana
15.Agni,kardama,Grandi visarpa26 Astanga hridaya nidana
16.agni,kardama,grandi,sannipata visarpa27 Madavanidana
17.Raktagata vata/Mamsagata Astanga hri.nidana/Sus.sam. nidana
medogata/Pittavrita vata/Pittavrita prana
vata/Pittavrita udana vata/PK yukta udana
vata 28
18.Krimi29 Madavanidana
30
19.Marma kshata Madavanidana
20.Vataja amlapitta/Adogata amlapitta Madavanidana
21.Majjagata masurika Madavanidana
22.Rakta pradaram Madavanidana
23.Dushi visham Madavanidana
Rupam references:
1. Madhu kosha comment
2. Cha.Nidana-11/
3. Asta.Sam.Nidana-1
4. Chakrapani comment
5. Madava nidana –jwara chap.
6. Cha.Sam.Nidana-jwara chap.
7. Asta.hri.nidana-jwara chap.
8. Asta.hri.nidana-kasa chap

49
9. Asta.hri.nidana-hridroga chap
10. Asta.hri.nidana-Trishna chap.
11. Madava nidana-Udavartha chap.
12. Asta.hri.nidana-madatyaya chap.
13. Madava nidana-madatyaya chap
14. Asta.hri.nidana-murcha chap
15. Madava nidana-chardi chap
16. Asta.hri.nidana-arshas chap
17. Madava nidana-arshas chap
18. Asta.hri.nidana-
19. Asta.hri.nidana-vidradi chap
20. Asta.hri.nidana-udaram chap
21. Madava nidana-udaram chap
22. Asta.hri.nidana-pandu chap
23. Madava nidana-pandu chap
24. Asta.hri.nidana-shopha chap
25. Madava nidana-shopaha chap
26. Asta.hri.nidana-visarpa chap
27. Madava nidana-visarpa chap
28. Sushri.sam.Nidana-Vata vyadi chap.
29. Madava nidana-krimi chap

50
SAMPRAPTHI:
Samprapthi is defined as the phenomenon of pathogenesis of a disease in a
healthy body.
The series of establishment of a disease and its exhibition of signs and symptoms
occurs in this process. Jati and Aagati1 are other synonyms for samprapthi.
The main event of samprapthi is “dosha dushya sammurchana”2.
I.SANCHAYA- Accumulation of dosha occurs
II.PRAKOPA- Vitiation of dosha occurs.
III.PRASARA- Spreading of the doshas in the body.
IV.STANA SAMSRAYAM- Dosha dushya sammurchana
V.VYAKTAVASTHA- Exhibition of signs and symptoms
VI.BHEDAVASTHA- Stage of complications.
I.SANCHAYAM:
Defined as accumulation of doshas in their respective places due to the nidana
factors 3.
All the vata prakopaka ahara viharas cause sanchayam of vata and pitta prakopa
ahara viharas can sanchayam of pitta.
In bhrama the mahjor doshas are vata and pitta hence when teekshnadi pitta gunas
associated with sheetala guna cause sanchayam of pitta. Rukshadi vata gunas associated
with ushna guna causes sanchayam of vata 4.

51
II.PRAKOPAVASTHA:
Aggravations of doshas in vilayana rupa are called prakopam5.
When vata, pitta are in sanchayavastha due to continuation of nidana factors the
doshas enters into prakopavastha. In this stage doshas are ready to dislodge from their
respective places.
For vata, dosha prakopa occurs in pravrit kala and varsha kaala when rukshadi
vata gunas associated with sheeta guna leads to vata prakopa 6.
In sharath ritu pitta prakopa occurs and when teekshnadi pitta gunas associated
7
with ushna guna leads to pitta prakopa .
III.PRASARAM:
When vata and pitta are in prakopavastha due to continuation oa vata ,pitta
prakopa ahara viharas and manasika karanas the doshas enters into prasaravastha. In this
stage doshas enters into the whole body or half of body or any part of the body and did a
8
place for the disease .
If nidana continuous further that place becomes stana samsraya for the disease.
In “bhrama” aggravated vata,pitta doshas which are there in prakopavastha are

enters into prasaravastha and make the hridayam and sarva shariram as stana for the
disease which further leads to stana samsrayam.
Prakopavastha doshas may be enters into the prasarvastha due to following
reasons9.
1. Exercise
2. Excessive heat form internal/external
3. Teekshna ahara/vihara/oushadha
4. Ahita ahara viharas.

52
IV.STANA SAMSRAYAVASTHA:
When doshas are in prasaravastha,if nidana continuous they reach the stana
samsrayavastha. It is also called as “dosha dushya sammurchanavastha”.
Actually in this stage the purva rupas of the disease will be occurs and dosha
dushya sammurchana also stays in first stage due to this reason the lakshanas of the
disease are appears in mild form10.
In “bhrama” the lakshanas like reeling sensation experienced by a patient forcing

him to lose his balance there by falling on ground.
V.VYAKTIBHAVAM:
When doshas are in stana samsrayavastha, if patient was not treated properly then
doshas enters into vyaktibhavam. In this stage the symnptoms (rupam)appears very
clearly11. After formation of the rupas also if not given trteatment then sroto vaigunyam
occurs this associated with dathus or malas then dosha dushy sammurcha occurs. Then it
12
establishes as a disease. But, it is not possible to name every disease .Treatment should
be given based on nidana karanas, doshas and adistana stanas of the doshas13.
In “bhrama” the major symptoms are reeling sensation experienced by a patient

forcing him to lose his balance there by falling on ground. Associated symptoms may
occurs like murcha, daham,shula and chardanam14.
VI.BHEDHAM:
After vyaktibhava avasta of the disease, if not treated then it becomes asadhyam15.
From sanchaya stage to bhedavasta stage the doshas becomes stronger, and then it
becomes hard to treat16.
“Bhrama” mentioned as a upadrava in gulma roga by charaka17and ajirnam,

vataraktam aamavatam, hridrogam by Madhavakara 18. When bhrama occurs in
madatyaya rogi it becomes asadhyam19.

53
Samanya Samprapthi:
By the constant and prolonged indulgence in the nidanas tridosha get’s vitiated as
a result agnidushti occurs. Because of this the consumed food will not get digested and
ama is produced. Here gunataha and karmathaha vriddi of vata, dravataha vriddhi of pitta
and gunataha vriddhi of kapha takes place. These doshas combines with ama and
produces Sama dosha. The Sama doshas travel through rasayani and spreads into hridaya
and takes tiryagati and reaches shakhagra. Because of the Sama dosha kha vaigunya takes
place any where between the rasavaha srotomula hridaya and sarvasharira. The
khavaigunya may be due to dosha dushti produced by nidana sevana or due to sahaja
karana. At the site of khavaigunya the tridoshas get’s sammurchita with rasa, rakta,
mamsa and meda, as a result, there will be derangement of rasavha, raktavaha,
mamsavaha, medovaha and manovaha srotas. Here, after dosha dushya sammurchana
following sequelae takes place.
Role of vitiated vata:

 Because of the vitiation of vata which is lodged in the blood vessels, the khara and
laghu guna causes katinya, leading to reduction in the elasticity; as a result of it
margavarodha is produced. This may be taken as arteriosclerosis. Even the age,
vriddhavastha, this is predominant of vata, comtributes to the pathology.
 Because of the vitiation of vata which is lodged in hridaya, the chalana or
praspandana karma of vyana vayu, prayatna karma of udana vayu and dharana karma
of prana vayu will be impaired. Because of this there will be impairment in the
initiation of contraction and relaxation, conduction of impulses, as a result of which
the increased doshas alter the functions of hridaya and increases the heart rate and
contration and relaxation, there by increasing the cardiac out put.
 When doshas get’s lodged in dhamani’s of vrikka, kleda samvahana is hampered thus
it adds to the blood volume resulting into increased cardiac output.
Role of vitiated Pitta:

By the Drava guna vriddi of pitta, the rakta vriddhi takes place due to
ashrayashrayi sambandha. Pitta is considered to have the identical qualities of that of

54
catacholamines. Since here the pitta vriddhi takes place, this can be attributed to increase
in catacholamines. Then, when found in increased level are liable to increase blood
pressure by increasing the peripheral resistance and cardiac output.
Role of vititated Kapha:

The picchila guna of kapha increases the viscosity of blood, which is also one of
the factors responsible in the mechanism of high blood pressure.
Role of Ama and Medas:

 The singdha, picchila, guru etc, guna of ama, excessive medas and apakwa medas
(improperly converted fat) accumulates in the blood vessels causing narrowing of
lumen of blood vessels, leading to margavarodha. This can be taken as
hypercholestraemic condition of the plasma.
 The increased medas can also cause mechanical compression over the blood
vessels from out side, which is also one of the factors for increased peripheral
resistance.
Role of Mamsa dhatu:

Ultimately hypertension in course of time produces thickening of the walls of
heart to cope up with increased function of it. This can be taken as cardiac hypertrophy
and this condition can be taken as adhimamsata which is the preliminary symptom of
mamsavaha srotodusti.
Thus a combined effect of all these pathological events, contribute to increased
peripheral resistance and increased cardiac output leading to hypertension.
At this stage the promonitory symptoms will arise, but here since it being a
vatavyadhi the purvarupa are said to avyakta and some vague symptoms like shiroshoola,
bhrama, anidra tec., may be seen with very mild intensity.
After this, the disease progresses and the complete manifestation of disease takes
place and as a result of these pathological events the signs like hypertension, bounding
pulse etc., are seen. And symptoms may or may not be present. If present, symptoms
comprises of bhrama, shirashula, anidra etc. Even at this stage, if the treatment is not

55
started, the further vitiation of doshas takes place and land up into complication or
upadrava. This depends on the sthana or the organ that gets affected i.e., when mastishka
is affected, the condition or diseases like ardita, pakshagatha etc., are produced,it causes
drishti mandya etc., and when hridaya is affected, it causes hridroga etc.,
SAMPRAPTHI GHATAKAS:
1. Dosha- shariraka- vata- vyana, prana, udana
Pitta- pachaka, sadhaka
Kapha - avalambaka.
Manasika- rajas, tamas
2. Dushya- Rasa, Rakta, Mamsa, Medho, Majja
3. Sanchara stana- Hridayam, sarva shariram
4. Agni- jataragni, dhatwagni
5. Ama- Jataragnimandyajanya, dhatwagnimandyajanya
6. Srotas- Rasavaha, Raktavaha, Manovaha
7. Srotodushti prakara- Atipravritti, Sangam
8. Adhistana- Hridaya, Dhamanis
9. Udbhava stana- Amashaya, Pakwashaya
10. Rogamarga- Madhyama, Bahya
11. Vyaktha stanam- Sarvadaihika.

56
SCHEMATIC REPRESENTATION OF SAMPRAPTHI OF

BHRAMA W.S.R.TO HYPERTENSION:
Continues indulgence in Nidana
Dosha prakopa
Agnimandhyam
Aamam
Saama doshas
Dosha prasara to Hridaya and Sarvasharira.
Dosha Dushya Sammurchana
Leads to folloing sequele
Vata Amam Medho Vata Pitta Rakta Kapha

Dushti.
Increased heart
Narrowing of Rate. Viscosity of blood.
blood vessels.
Cardiac Output
Bhrama
Blood volume
Peripheral resistance
Hypertension

57
CLASSIFICATION OF HYPERTENSION:
Hypertension can be classified in several ways.

1. Systolic and Diastolic hypertension
2. Essential and Secondary hypertension.
3. Intermittent and Established hypertension.
4. On the basis of Severity.
1.Systolic and diastolic hypertension:

Systolic and diastolic hypertension often coexists but when theyt donot ot the two
the diastolic hypertension has greater significance. However recent epideological studies
have shown that systolic hypertension alone does shorten life.
I.Renal:
1. Chronic pyelonephritis
2. Acute and chronic glomerulonehpritis
3. Polycystic renal disease
4. Renovascular stenosis or renal infarction
5. Most other severe renaldiseases (Arteriolarnephrosclerosis,diabetic
nephropathy)
6. Renin producing tumours.
II.Endocrine:
1. Oral contraceptives
2. Adrenocortical hyperfunction.
a. Cushing disease and syndrome.
b. Primary hyper aldosteronism.
c. Congenital or hereditary adrenogenital syndromes.
(17 α-hydroxylase and 11β-hydroxylase defects).
3. Pheochromocytoma.
4. Myxoedema.
5. Acromegaly.

58
III.Neurogenic:
1. Psychogenic
2. Diencephalic syndrome
3. Familial dysautonomia
4. Polyneuritis (acute porphyria/lead poisoning)
5. Increased intracranial pressure (acute)
6. Spinal cord section (acute)
IV.Miscellaneous:
1. Coarctation of aorta
2. Increased intravascular volume (excessive transfusion, polycythemiavera)
3. Polyarteritis nodosa
4. Hypercalcaemia
5. Medications eg: glucocorticoids, cyclosporine.
V.Unknown etiology:
1. Essential hypertension (>90% of all cases of hypertension)
2. Toxaemia of pregnancy
3. Acute intermittent porphyria.
2.Essential and Secondary hypertension:
Hypertension may be essential in the sense that it is primary or without known

cause or it maybe secondary disease of some other organ, such as the kidney, endocrine
gland, central nervous system or aorta.
3.Intermittent or established hypertension:

Hypertension may be intermittent (labile) or established (sustained):very often the
formed is merely an early stage of the later.
A commonly accepted classification would be the one adopted from the sixth
report of the joint national committee on detection, evaluation and the treatment of high
blood pressure (JNC VII) archives of internal medicine.

59
4.Classification of blood pressure on the basis of severity.
Classification Systolic blood pressure Diastolic blood pressure

Normal <120 <80
Prehypertension 120-139 80-89
Stage I 140-159 90-99
Stage II >160 >100
*Based on the average of ≥2 readings take at each of two or more visits after an initial
screening.
Note: Classification of blood pressure for adults aged 18 yr and older not taking anti
hypertension drugs and not actually ill. When systolic and diastolic pressures fall into
different categories, the higher category should be selected to classify the individual’s
blood pressure status.
Inclusion Criteria:
(Based on “International Classification of Diseases -10”)
 Essential hypertension(Primary hypertension)
 High blood pressure.
 Hypertension- (arterial)(Benign)(Essential)(Malignant)(Primary)(Systemic).
Exclusion Criteria:
 Involving vessels of brain
-Sub Arachnoid Haemarrhage
-Intra Cerebral Haemarrhage
-Non-traumatic intracranial haemarrhage
-Cerebral infarction
-Stroke
-Occlusion and stenosis

60

-Cardio Vascular diseases
-Cardio vascular diseases.
-Sequel of Cardio vascular diseases.
 Involving vessels of Eye and Retinal disorders.
SAMPRAPTHI REFERENCES:
1. Asta.sam.nidana-1
2. Madhukosha –comment “dosheti kartavyatopalakshitam vyadi janma
samprapthi”
3. Asta.hri.sutra-12/1 “chayovriddi svadamneva pradweshovriddi hetushu viparita
gunnechacha”
4. Asta.hri.sutra-12
5. sus.sam.chi-33/ dalhana comment
6. Asta hri.sutra-12
7. cha.sam.sutra-6/
8. sus.sam.sutra-18/
9. Cha.sam.sutra-18
10. Cha.sam.chi-11
11. Madhava nidana-introduction
12. Cha sam.sutra-18
13. Cha.sam.sutra-18
14. Cha.sam.chi-28/220 or Sus.Sam.Nidana-1/35 or Asta.hri.nidana-16/42
15. Sus.sam.sutra-21
16. Sus.sam.sutra-21
17. Cha.sam nidana-gulma chap
18. Madhavanidana
19. Madhavanidana-madatyaya chap.

61
PATHOGENESIS OF ESSENTIAL HYPERTENSION:
The pathogenesis of essential hypertension is not completely understood;

therefore we will have to content with describing some of the theories of essential
hypertension.
Arterial hypertension occurs when changes develop, that alter the relation ship
between blood volume and total peripheral resistance. For many of the secondary forms
of hypertension, these factors are seasonably well understood, but for essential
hypertension, these factors are reasonably well understood, but for essential hypertension
it is till obscure.
It is currently believed that essential hypertension results from an imbalance
between the mechanisms controlling-
1. Sodium homeostatis.
2. The sympathetic nervous system.
3. The rennin-angiotensin-aldosterone system.
4. Circulating vasoconstricting and vasodilating agents.
5. Neurotransmitters.
6. Insulin resistance.
7. Cell membrane alterations.
8. Endothelial dysfunction.
1) Sodium Homeostasis:
Most authorities believe that impaired renal sodium excretion is one of the first
changes in the development of hypertension. Sodium retention is followed by an
expansion of blood volume and a subsequent increase in cardiac output.
Essential hypertension appears to be a pathological condition due to an alteration

in the transport system for sodium and potassium. This results in a rise in the extra-
cellular sodium ion concentration, thus leading to a disturbance of sodium homeostasis.

62
2) The Sympathetic Nervous system:

Most sympathetic nerve endings release a hormone called nor-epinephrine. This
causes vasoconstriction of arterioles in the skin and splanchnic area leading to a rise in
blood pressure.
Sympathetic over activity can rise blood pressure by a variety of mechanisms, by
a direct vasomotor effect, by central action on the brain or by acting in association with
the rennin-angiotensin system causing sodium retention by acting on the kidneys.
3) Renin-Angiotensin-Aldosterone Sysytem:
The rennin-angiotensin-aldosterone axis increases blood pressure by increased
formation of angiotensin, increased sympathetic output; and increased aldosterone
secretion. Aldosterone increases re absorption of sodium and excretion of potassium in
the the kidneys. The two important stimuli leading to the release of rennin are a reduction
in afferent arteriolar pressure and sodium depletion.
Angiotensin is a powerful vasoconstrictor and is therefore capable of producing
hypertension. Angiotensin-II also stimulates aldosterone secretion from the adrenals.
In brief, reduced renal perfusion pressure leads to the production of renin and angiotensin
and further to salt and water retention. Thus a vicious circle may be established.
4) Circulating vasopressor and Vasodilator agents:

Peripheral vascular resistance is controlled by vasoconstrictors and vasodilators.
There is some evidence at present that the altered activity of vasopressor and vasodilator
agents may be involved in the pathogenesis of essential hypertension. The circulating
vasopressor agents include angiotensin-I, catecholamine, thromboxane, leucotrienes and
endothelin-I. Recently a new group of vasoconstrictors, the endothelins has been
identified. Endothelin-I is a powerful vasoconstrictor.
Two of the most powerful vaso-active mediators, nitric oxide and endothelin have
been discovered recently and both occur within endothelial cells. Nitric oxide is the
principle physiological vasodilator while endothelin is the most important
vasoconstrictor.

63
The kidney produces circulating vasodilators or angiotensive substances such as

prostaglandins, a urinary kallikrein-kinin system and platelet activating factor.
Abnormalities in the production of vasodilators are implicated in the pathogenesis
of hypertension. Arterial natriuretic peptide (ANP) is another additional circulating
vasodilator factor which is involved in the regulation of sodium and water excretion and
therefore influences blood pressure. ANP hormone is secreted by specialized cells in the
cardiac atria in response to expanded blood volume. ANP binds to specific receptors in
the kidneys and increases the urinary excretion of sodium. The renin-angiotensin-
aldosterone system is opposed by ANP, a vasodiloator. ANP dilates blood vessels, and
therefore has antihypertensive properties. At present, the relation between plasma levels
of ANP and hypertension is not clear.
5) Neurotransmitters:
Neurotransmitters disturbance influences the development of essential
hypertension. Disturbance of neurotransmitters including acetylcholine, noradrenaline,
substance P, neuropeptide Y, serotonin, dopamine and encephalin play a role in the
pathogenesis of essential hypertension.
6) Insulin Resistance:
Insulin resistance and /or hyper insulinaemia have been suggested as being
responsible for the increased arterial pressure in some patients of hypertension.
Hyperinsulinaemia produces renal sodium retention and increases sympathetic activity.
Either or both of these effects could lead to an increase in arterial pressure.
7) Vascular Endothelium in Hypertension:

The endothelium produces vaso active substances that regulate vascular smooth
muscle function and structure. A functional or healthy endothelium maintains a balance
between opposing states; dilation versus vasoconstriction ect.. in the functional
endothelium, low level of nitric oxide(NO)is continuously released to keep the blood
vessel in the state of dilatation.

64
In the physiologic state, the endothelium maintains the vascular tone. Under patho
physiologic conditions, however, tissue cells of vaso constrictive substances such as
angiotensin II increase. Angiotensin II also stimulates the release of endothelin, the most
potent vasoconstrictor.
8) Leptin Link to Hypertension:

Leptin is one of the regulators of blood pressure. Persons with high leptin levels
have elevated diastolic blood pressure.
9) G.Protein:
A recent study suggests that mutations in G.Proteins can lead to essential
hypertension.

65
Table showing the hypothetical scheme for the pathogenesis of Essential

hypertension:
Genetic influences Environmental factors
Defects in renal
sodium hemostasis
Inadequate sodium
excretion
Salt and Water

retention
Plasma & ECF Vascular

volume reactivity Vascular wall
thickness
Cardiac Output
Total peripheral
resistance
Hypertension

66
PATHOLOGY:
The adverse effects of long standing systemic hypertension principally involve
small arteries, and arterioles, the heart, kidneys, brain and retina. The primary vascular
changes can cause damage in the kidneys, brain and retina. Hence the pathological
lesions of systemic hypertension can be grouped under two broad categories;
A) Arterial and cardiac lesions.
B) Effects of arterial lesions on other organs.
Arterial and cardiac lesions:

Heart:
In systemic hypertension, the left ventricle has to deal with an increased
resistance against blood ejection. This results in development of marked hypertrophy in
order to cope with the increased work load. Cardiac hypertrophy is the result of increased
total peripheral resistance resulting in increased work over a long period of time.
Arteries:
Systemic hypertension affects the arterial wall partly physically and partly
through the action of chemicals released from the kidney and the nervous system. The
main effect of hypertension on large and medium arteries is the significant promotion of
the atherosclerosis, achieved primarily by injuring the endothelium and making it more
permeable to large atherogenic lipoprotein molecules.
Hypertension can affect small arteries and arterioles in any one or a combination of the
following three ways.
1. Hyaline (Benign) arteriosclerosis;
2. Hyperplastic arteriosclerosis;
3. Necrotizing arteriolitis or “Fibrinoid necrosis” of arterioles;
Hypertension can change a normal arteriole (A) in the following ways. It can
thicken its wall and diminish its lumen by inducing an insulation of plasma into the wall
(hyaline arteriolar sclerosis). It can thicken its wall and narrow the lumen by causing

67
proliferation of wall myocytes (“hyperplastic arteriolar sclerosis”). It can cause necrosis

of part or the whole wall (“necrotizing arteriolitis”); this can in turn induce hemorrhage.
or thrombosis.
Effects of Arterial Lesions on other organs:

Kidneys:(Hypertensive renal disease):
Changes in renal arterioles occur in most cases of hypertension. Microscopically
the afferent arterioles show necrotizing arteriolitis. Some small sized blood vessels also
show cellular hyperplasia (productive endarteritis),in which due to concentric cellular
hyperplasia, the wall looks like an onion skin.
Brain: (Hypertensive cerebral disease):

Hypertension adversely affects the brain in a variety of ways. In the brain,
malignant hypertension can produce a massive hemorrhage mostly due to the rupture of
several necrotic arterioles at a time, but sometimes also due to the rupture of the
distended and weekened wall of congenital arterial “berry aneurysma”.
In hypertensive encephalopathy, pathologically, the brain shows cerebral oedema

and petechial haemorrhages. Walls of small arteries and arterioles may snow fibrinoid
necrosis.
Idiopathic intracranialo hypertension (IIH), also known as pseudotumour cerebri is

characterized by increased intracranial pressure without enlarged ventricles or mass
lesions.
The pathophysiology of IIH is unknown. Elevated intracranial venous pressure has been
suggested as a universal mechanism in IIH of various etiologies. The only significant
complication of IIH is visual loss.

68
Retina: (Hypertensive retinopathy):

In the retina, the retinal arterioles show all the changes of hypertension on
fundoscopic examination. The changes due to severe hypertension are;
a) Hypoxia due to the thickened walls and narrowed lumen of arterioles, which an
fundoscopy look like “Silver wires”.
b) Patches of oedema due to the increased endothelial permeability of arerioles
and capillaries, and
c) Haemorrhages due to the rupture of several injured small vessel walls.
The clinical results of the above are visual disturbances ranging from blurring of
vision to complete blindness (Scotoma). Hypertensive retinopathy is classified according
to the severity of above lesions from Grade I-IV. More serious and severe changes with
poor prognosis occur in higher grades of hypertensive retinopathy.
Keith and Wagner’s Grading of Hypertensive Retinopathy:

Grade-I Thickening and tortuositry of arteries showing silver wiring appearance.
Grade-II Grade I changes plus arteriovenous nipping.
Grade-III Grade II changes plus flame shaped (superficial)haemorrhages and cottonwool
exudates.
Grade-IV Grade-III changes plus papilloedema.

69
DIFFERENTIAL DIAGNOSIS:
In modern science essential hypertension should be differentiated from secondary
hypertension. Following are the differentiating features.
FACTORS ESSENTIAL HYPERTENSION SECONDARY

HYPERTENSION.
INCIDENCE 95% 5%
ETIOLOGY Unknown etiology Renaldiseases,renovasculardise
ases,renal neoplasms,
endocrine diseases, drug
induced etc.,
HISTORY A strong family history of Often develops before the age
hypertension, along with reported of 35or after 55.history of use
finding of intermittent pressure of steroids or estrogens is of
elevation in the past favours the obvious significance.
diagnosis of essential hypertension.
PATHOLOGY Pathogenesis is not clearly Pathogenesis and pathology
understood and pathology pertains to depends on the disease that has
heart and blood vessels caused hypertension.
BLOOD A rise in diastolic pressure when the A fall in the absence of
PRESSURE patient goes from the supine to the antihypertensive medication
RECORDING standing position is most compatible with the treatment of the cause,
with essential hypertension. suggest secondary forms of
hypertension.
SYMPTOMS Symptomatic or asymptomatic, Symptoms will be present with
vague symptoms like headache, the underlying disease.
bhrama, easy fatigability etc., will be
present.
INVESTIGATI Urine analysis and Depending on underlying the
ONS microscopy,serumurea,creatinine,uri disease, the values of these

70
cacid,serum electrolytes,fasting laboratory investigations and

glucose,fasting lipids,ECG and chest ECG and chest X-ray varies.
X ray. The values of all laboratory Here some special studies are
investigations will be within normal needed to screen for secondary
range. ECG and chest X-ray will be hypertension.
normal.
PROGNOSIS It is controllable with proper It is curable .when cause is
treatment. It requires life long treated, the elevated blood
monitoring and treatment may pressure comes down to
require periodic adjustments. normal.
TREATMENT Treatment comprises of Treatment depends on the
1.Non drug therapy cause and requires drug
 Relief of stress therapy during severe
 Dietary management condition.
 Regular aerobic exercise
 Weight reduction
 Control of other risk factors
2.Drug therapy
In general six classes of drugs are
used.
 Diuretics
 Antiadrenergic agents
 Vasodilators
 Calcium entry blockers
 ACE Inhibitors and
 Angiotensin receptors
antagonists

71
COMPLICATIONS:(UPADRAVAS)
The occurrence of another disease in the wake of primary disease, as a
complication or sequel, is termed as upadrava (Madhukosha).
Sushritha while mentioning upadravas of mahagada, in which vata vyadhi is one

amongthem, explainspranakshaya, mamsakshaya, jwara, atisara, murcha, trishna, hikka,
shosha, chardi, shwasa. Dalhana commenting on this says some acharyas considers
shotha in place of shosha. So thus here shotha, shwasa i.e., edema and dyspnoes can be
taken as the complications. Most of the acharyas considers essential hypertension to that
of avrita vata rogas and even some lakshanas also correlates with avritha vata rogas.
Acharya charaka while explaining the upadravas of avritha vata rogas mentions Hridroga
as one of the complications.
In modern science the complications of essential hypertension can be classified on

the basis of –
 Target organ damage
 Atherosclerotic and pressure induced.

72
COMPLICATIONS OF ESSENTIAL HYPERTENSION:
ORGAN COMPLICATIONS
ATHEROSCLEROTIC PRESSURE INDUCED
BRAIN Cerebralinfarction, Hypertensiveencephalopathy,
Transient ischaemic Cerebral haemorrhage,
attacks Lacunar infarcts
EYE Retinal vascular accidents Exudative and haemorrhagic
changes,Papilloedema.
HEART Angina,Myocardiac Hypertensive heart disease, Left
infarction,Sudden death ventricularhypertrophy,cardiomagaly,
ECGabnormalities,
congestive cardiac failure.
KIDNEY Renovascular disease Arteriolar nephrosclerosis,
Benign-without fibrinoid,
Malignant-with fibrinoid.
PERIPHERAL Intermittentclaudication, Aneurysms, aortic dissection.
ARTERIES Vascular occlusion.

73
DIAGNOSIS AND ASSESSMENT:

Hypertension should not be diagnosed on the basis of the single measurement
unless there is target organ damage (TOD) or SBP-160-210 mm of Hg or DBP100-120
mm of Hg. Otherwise, the initial elevated readings should be conformed on at least 2
subsequent visits. The reevaluation may be done within days or weeks depending upon
the level of the initial blood pressure.
The objectives of evaluating a newly diagnosed hypertensive patient should be to
search for causes, define target organ status and look for other atherogenic risk factors.
A complete history should be taken. Symptoms of TOD as well as concomitant
conditions that increase morbidity and mortality such as diabetes, obesity and hyper
lipidaemia should be noted. A history of smoking, alcohol and sodium intake is also
relevant. In the family history, attention should be payed to the presence of hypertension,
diabetes, hyperlipidemia, ischaemic heart disease and stroke.
Secondary causes of hypertension should be excluded. These include renal
parenchymal disease, endocrine disorders, coarctation of the aorta and renovascular
hypertrension. A history of intake of oral contraceptives, non-steroidal anti-inflammatory
agents, steroids, nasal decongestants and liquorice should be enquired.
Physical examination should aim at assessing TOD, excluding secondary causes
of hypertension and identifying concomitant risk factors. These include:
 General examination including height and weight.
 Blood pressure measurement.
 Carotid bruit, renal artery bruit and peripheral pulses.
 Cardiac examination.
 Respiratory examination.
 Abdominal masses eg., polycystic kidneys.
 Fundoscopy.
The initial workup should include the following investigations:

74
 Urine analysis and microscopy.

 Serum urea, creatinine, uricacid.
 Serum electrolytes.
 Fasting glucose
 Fasting lipids.
 Electrocardiogram (ECG) and chest X-ray.
If the examination or investigations suggest a secondary cause, the patient should

undergo special evaluation. If there is TOD further tests should be done to evaluate
the severity.

75
CHIKITSA:
1
Vyadhiharana kriyas are known as chikitsa . Roga nidana pratikaras are also
2 3
called as chikitsa . Sushritha mentioned as “nidana parivarjana” as a chikitsa .
In every disease the nidana is compulsory to manifest the disease. Its parivarjana
itself becomes treatment for that disease.The treatment which is going to be done by
ahara, viharas and oushadha dravyas are called as “yuktivyapashraya chikitsa” 4.
In “bhrama” the major doshas are vata and pitta. Vata and pitta hara ahara and
viharas and medhya dravyas are useful to treat the bhrama. “Bhrama” was mentioned in
5 6
“pittavrita prana vata” by charaka and vagbhata .Charaka mentioned treatment for
“pittavrita vata” in his chikitsa stana 7.
He mentioned that ushna rupa chikitsa and sheeta rupa chikitsa should be done in
alternatively until the lakshanas subside.Jeevaniya gana dravya grita indicated for this.He
mentioned Jangala jantu mamsam, yava,shali as a aharas for pittavrita vata. Yapana vastis
8
and ksheera vastis are also mentioned .
REFERENCES:
1. Vaidyaka shabha sindhu-“ya kriya vyadhi harani saa chikits nigadyate”
2. Vaidyaka shabha sindhu-“chikitsa roga nidana pratikara”
3. Sus.sam.Uttara-1/25
4. Cha.sam.sutra-21
5. Cha.sam.chi.-28/220
6. Asta.hri.nidana-16/42
7. Cha.sam.chi-28/184
8. Cha.sam.chi-28/185.

76
TREATMENT:
Hypertension is highly prevalent and powerful contributor to cardiovascular
morbidity and mortality in the general population. The high prevalence of this condition
continues despite the introduction of increasingly effective number of anti-hypertensive
agents. It is blood pressure that kills hypertensives, not hypertension.
Once diagnosed, hypertension requires on going management, despite the absence

of symptoms. The goal of treatment in patients with hypertension is to prevent morbidity
and mortality associated with high blood pressure by least intrusive means possible. The
benefits of treatment have to be weighed against side effects and inconvenience, so it is
important to treat the whole patient, not just the blood pressure. This can be to a large
extent accomplished by achieving and maintaining SBP<140 mm of Hg and
DBP<90mmofHg with the most cost effective means while maintaining good quality of
life.
Treatment of blood pressure encompasses non-pharmacological and

pharmacological measures. Non-pharmacological intervention through life style
modification is advocated as initial therapy for essential hypertension.
Non-Pharmacological Management includes:

 Relief of emotional and environmental stress.
 Sodium intake: Elderly people are more sensitive to sodium intake. An
intake<100 m mol or 6 gm sodium chloride a day us recommended.
 Weight reduction: weight reduction is most beneficial in patients who are more
than 10% over weight. As far as possible, aim for ideal Body Mass Index(BMI)of
20-25 kg/m2.however even a 5%reduction in weight will result in significant
lowering of blood pressure.

77
 Avoidance of excessive alcohol intake: the intake should not exceed 21 units per
week for men and 14 units per week for women. One unit of alcohol is equivalent
to ½ a pint of beer or 100ml of wine or 20ml of proof whisky.
 Reduction of cholesterol and saturated fat intake: as with smoking, this is
important in reducing cardiovascular risk.
 Regular physical exercise: dynamic isotonic exercise(eg., Jogging, walking.,) is
more effective than static isometric exercise(eg., weight lifting). Milder exercises
like brisk walking for 30-60minutes 3-5 times a week is preferred.
 Cessation of smoking: This is important in the overall management of the
hypertensive patient in reducing cardiovascular risk.
 Other non-pharmacological management includes micronutrient alterations and
dietary supplementation with fish oil, potassium, calcium, magnesium and fiber.
However they have limited or unproven efficacy.
TREATMENT INTERVENTION B.P.REDCUTION(mmofHg.)

Sodium restriction Dietary advice sodium 8-15 systolic
intake(<100m mols/day) 5-6 diastolic
Relaxation Relaxation techniques 9-27 systolic
4-16 diastolic
Weight loss Diet and exercise 9-27 mean arterial pressure
Exercise Aerobic exercise 6-13systolic
programme 9-12 diastolic.

78
Table showing initiation of modern treatment in patients with

hypertension.
SBP 140-180 (or) DBP 90-110 mmofHg.
Assess other risk factors TOD
Initiate life style mesures
Stratify absolute risk
Veryhigh High Medium Low
Monitor BP& Monitor BP &

Begin with Begin with Other risk Other risk
Drug Drug factors for 3- factors for 6-12
6months months
SBP ≤150
SBP ≥150 DBP ≤95
SBP ≤140 or orDBP ≥95 Continue to
SBP≥140 or DBP ≤90 Monitor
DBP≥90 Begin Begin Drug.
Continue to
Drug. Monitor

79
Pharmacological management:
If non-pharmacological treatment does not succeed during 4-6 month period or if
the level of blood pressure is high, immediate antihypertensive drug therapy should be
implemented.
Approach to drug therapy:
The aim of drug therapy is to use the agents just described, alone or in
combination to return arterial pressure to normal levels with minimal side effects.
General principles:
1. Start with a low dose of an agent and, if blood pressure is not controlled, increase only
moderately.
2. Star with an agent that may also treat and /or not harm a coexisting condition.
3. Add a second agent from a different, complementary class if blood pressure is not
controlled with a moderate dose of the first agent.
4. Start with an agent that the patient is likely to tolerate best; long term compliance is
related to tolerability and efficacy of the first agent used.
5. Use a diuretic when two agents are used, in nearly all cases.
6. Use thiazide diuretic only at low doses,i.e, ≤25 mg/d of hydrochlorothiazide or its
equivalent, unless some pressing reason exists.
7. Use low dose combination therapy when appropriate as initial therapy;
a) A diuretic with a beta blocker, ACE inhibitor or a beta blocker.

b) A calcium channel blocker with an ACE inhibitor or a beta blocker.
8. One or two agents will control blood pressure in 90% of hypertensive patients.
If therapy with two drugs does not achieve blood pressure control, the primary
agent should be increased to full dose. If the blood pressure is still not controlled, then a
detailed search for a secondary cause of hypertension is indicated. If none is found, then a

80
dietary assessment will often reveal a high sodium intake. With reduction in salt intake ti
5gm/day or less, blood pressure is often controlled.
If the blood pressure is controlled, then a stepwise reduction in the and /or with
drawl of some of the agents should be carried out to determine the minimal therapeutic
programme that will maintain the blood pressure at 140/90mmofHg or less. Whether
triple or quadruple drug therapy is warranted to lower blood pressure, further is uncertain.
In general, there are sex classes of drugs; diuretics, anti adrenergic agents,
vasodilators, calcium entry blockers, angiotensin converting enzyme (ACE)inhibitors and
angiotensin receptor antagonists.

81
CLASS COMPELLING POSSIBLE COMPELLING POSSIBLE

OF INDICATIONS INDICATIONS CONTRA CONTRA
DRUG INDICATIONS INDICATIONS
DIURE Heart failure, Diabetes Gout Dyslipidemia,
TICS
elderly patients, sexually active
systolic males
hypertension.
Β- Angina, after Heart failure, Asthma, COPD, Dyslipidemia,
BLOCKE
myocardial pregnancy, heart block. athletes
RS
infarct, diabetes &physically active
tachyarrhythmias patients, peripheral
vascular disease
ACE INHI Heart failure, Pregnancy,
BITORS
LVF, after hyperkalaemabi
myocardial lateral renal
infarct, diabetic artery stenosis.
nephropathy.
CALCIM Angina, elderly Peripheral Heart block Congestive heart
ANTA
patients, systolic vascular disease failure
GONISTS
hypertension
Α-BLOCK Prostatic Glucose Orthostatic

ERS
hypertrophy intolerance, hypotension.
dyslipidemia
ANGIOTE ACE-inhibitor Heart failure Pregnancy,hype
NSIN II
cough. rkalaemia,
ANTAGO
bilateral renal
NISTS
artery stenosis.

82
PATHYAPATHYA:
In the treatment of the diseases, Pathyapathyas are given equal importance with
drugs, diet and therapeutic measures.
The pathyapathya that can be recommended on the basis of dosha dushyadi are as
follows.
Table showing the pathyapathya in Hypertension(Bhrama):
PATHYA APATHYA
AHARA Mudga,masoora,yava,palaka, Anupa desha pakshimamsa,
methica,jambeera,carrot,papaya, dadhi,dugda vikara,tobacco,tea,
drygrapes,orange,ardraka,rasona, coffee,salt,fatty substances,
hingu,jeeraka,maricha, alcohol,etc.,
jangala pakshi mamsa,godugda,
ajadugdha,takra etc.,
VIHARA Samyakvishrama,upavasa,shavasaa, Diasvapna,ativyayama,avyayama,
samyak vyayama,sadvrittapalana, vegadharana,adhyashana,
nitya abhyanga,Krodha-irsha-bhaya- atichintana,atikrodha,atishrama,
chinta-shokadi dharaniya vega atisukhasana,ratrijagarana etc.,
dharana,etc.,

83
CRITIRIA FOR THE SELECTION OF THE DRUGS:

The present compound used in the clinical trial is a combination of individual
drugs taken from “Bhavaprakasha nighantu”. This is named as “Karpasa Beejadi Gritha
Gutika”. This is anubhutha yoga.
All the drugs have vata, pitta hara and medhya properties. All the drugs are easily
available, non controversial and economical.
The disease “Bhrama”basically is a vaata, pitta predominant disease hence this

compound shall effectively counter the effects of vitiated vaata, pitas. As it also has
mehdhya property, it enhances the intellectual capacity of the brain.
This compound drug having the properties of madhura, tikta, kashaya rasas, guru
snigdha gunas, Sheeta virya and madhura vipaka predominantly. Due to Madhura, Tikta,
Kashaya rasa it acts as vata pitta shamaka. Almost all the drugs are having the medhya
property which is useful for enchance the intellectual capacity as well as acts as
anxyiolytic.
Guduchi is an immunomodulator, tridosha shamaka and medhya rasayana.

Aparajitha has a property of tridoshahara and medhya. Shatavari is a vata pitta hara drug
and Rasayana. Jatamansi is a tridoshahara and medhya. Karpasa beeja has a property of
VP hara and vrishya.
Gogritha is the only bhavana dravya for this compound. This is having the
madhura rasa, guru guna, sheeta virya and madhura vipaka. It is also a nitya rasayana. It
is vatapitta haram and Medhagnivardakam.Go gritham increases the HDL-cholesterol
levels and hence it is cardioprotective.

84
Description of individual drugs:

1.GUDUCHI:
Botanical name : Tinospora cordifolia
Family : Menispermaceae
Synonyms : amritha, avyatha, amritavalli, guduchika,
gundra,chakrangi,kundali
Properties:
RASA : Tikta, Kashaya
GUNA : Guru, Snigdha
VIRYA : Ushna
VIPAKA : Madhura
KARMA : Tridoshashamaka, medhya, rasaya, dipaniya, grahi,
Medhohara, kandgna, jwarahara, dahaprashamana.
PARTS USED: Stem, root, areal roots
DOSE : Stem powder: 3-6 gm

Decoction: 50-100ml
Fresh juice: 10-20ml
Guduchi satva: 1-2 gm
Chemical constituents: A diterpine of columbin type-tinosporin is isolated from

plant.
Tinosporidine and beta sitosterol isolated from stems. Cordifor, heptacosanor and
octacosanol reported from the leaves. A new furanoid diterpine-tinosporide from
stems.18-norclerodene glucoise-tinosporaside from stem wood is reported.
Iso columbin, tetra hydropalmatine, magnoflarine and palmatine were isolated
1
from roots.It is mentioned in Hridroga by vanga sena .

85
References:
1. Vanga sena- vata vyadhi prakarana
2. Bhava prakasha nighantu-3/1-10.
3. Dhanvantari nghantu 1/1-4,
4. Shodhala nighantu-1/96-98.
5. Cha.sam.Sutra-25/
Guduchi:
“Rasoguduchyaasthu samula pushpyah kalka prayojyah khalu shankha pushpyah
Aayuh pradhaanyamaya nashanaani balagni varna swara vardhanaani,
Medhyaani chaitani rasaayani medhyani vishesheenacha shankhapushpee”
(Cha.Sam.Chi.1.3.30-31)
2.APARAAJITHA:
Botanical name : Clitoria ternate
Family : Fabaceae
Synonyms : Aspotha, Gririkarni,Vishnukrantha, Swetha, Mahaswetha.
Properties:
RASA : Katu, Tikta, Kashaya
GUNA : Laghu, Ruksha
VIRYA : Sheeta
VIPAKA : Katu
KARMA : Tridosha hara, medhya, vishagna, chakshushya.
INDICATIONS : Kushta, shotha, unmada, vrana, shula.
PARTS USED : Root/Root bark; Seeds
DOSAGE : Root powder: 1-3gm.
Seed powder: 1-2gm.
Chemical constituents:
Aparajitin,tetraxerol,taraseron,alphaandbetasitosterols,robinin,quercitin,kaempfer
ol,ternatines A,B,C,D.It was mentioned in manasika rogas by raja marthanda.

86
References:
1. Bhava prakasha nighantu.
2. Raja marthanda.
“Aparaajithe medhye sheete kantye sudrishtide
Kushtamutra tridoshaama shotha vrana vishaapahe,
Kashaye katuke paake tikte cha smriti budhdhide”
(Bhava prakasha.)
3.SHATAVARI:
Botanical name : Asparagus racemosus.
Family : Liliaceae
Synonyms : Indivara, Bahusuta,Madabanjini,Satamuli,
Sheetavirya,Atirasa.
Properties:
RASA : Madhura, Tikta
GUNA : Guru, Snigdha
VIRYA : Sheeta
VIPAKA : Madhura
KARMA : VP hara, Rasayana, Vrishya, Stanya janana.
INDICATIONS : Stanyakshaya, Artavakshaya, Raktapitta,Arshas,
Atisaara, Grahani, Kshaya, Gulma.
PARTS USED : Tuberous roots
DOSAGE : Fresh juice: 10-20ml.
Decoction: 50-100ml.
Powder: 3-6gm.
From roots: Sarasapogenin,two spirostanolic and two furostanolic
sponins,sitosterol,asparaganine A.

87
From fruits: beta-sitosterol, sarasapogenin, diosenin, Asparanins A and B.

From leaves: Favonoids, rutin.
The glycosidal fraction (0.5mg) of the plant produced bradycardia and reduction
in the force of contration.
A high dose (60mg/kg) produced a fall in blood pressure and depression of the
respiration of cat.(Roy et al., 1968,1971).
References:
“Medhaagni pushtidha snigdha netrya gulmaatisarajit
Shukrastanya kari balyaa vatapittasra shotha jit”
4.JATAMAMSI:
Botanical name : Nardostachys jatamamsi
Family : Valeianaceae
Synonyms : Tapaswini,Nalada,Bhutajata,Vilomasha,Jata, Mamsi,Mura.
Properties:
RASA : Tikta, Kashaya, Madhura
GUNA : Laghu, Snigdha
VIRYA : Sheeta
VIPAKA : Katu.
KARMA : Tridoshahara, Medhya, Balya, Kushtagna.
INDICATIONS : Kushta, Kandu, Visarpa, Jvara, Daha.
PARTS USED : Rhizome.
DOSE : powder: 1-3 gm.

88
Actinidine,carotene,aristolens,calarene,elerid,droaristolene,bendesmol,JatamolsA
andB,Jatamansicacid,Jatamansone,Nardol,Nardostachonol,Nardostachone,Jatamansin,Jat
amansinol,Oroselol.
Research:
1. The essential oil from the rhizomes has a depressant action on the CNS of guinea pigs
and rats. (Chopra et al., 1954).
2.Thi oil free aquous extract showed a transient hypotensive effect and ECG changes in
dogs heart, apart from contracting frogs rectus muscle.The CVS effect of the extract was
similar to that of potassium.(sheth and kekra., 1956).
3. The alkaloid fraction showed a significant and sustained hypotensive action in dogs.
(Dose et al., 1957b).
4. Root powder showed a sedative action in a clinical study on 24 medical students as
evidenced by the prolongation of the visual reaction time. (Amin et al., 1961).
“Mamse tiktaa kashayaacha medhyaa kanti bala prada

Swadvee himaa tridoshaasra daha visarpa kushtanuth”
(Bhava prakasha)
5.KARPAASA BEEJA:
Botanical name : Gossypium herbacium.
Family : Malvaceae
Synonyms : Tundikeri, swadanshtra.
Properties:
RASA : Katu
GUNA : Tikshna, Snigdha (Root bark-Laghu)
VIRYA : ushna
VIPAKA : Katu

89
KARMA : VP hara, Seed-vrishya, Leaf-mutrala, stanya janana.

INDICATIONS : Karna puya, karnanada, mutrakrichcha, anartava, kashtartava.
PARTS USED : Root, Flower, Seed.
DOSE : Decoction: 50-100ml;
Seed powder: 3-6 gm.
Root : hemigosypol;
Flowers : quercimetitrin;
Seed : gossypol;
Essential oil : caryophyllene, Pinene, Limonene.
References:
“Karpasako …….tatbheejam syandham vrishyam snigdham kaphakaram guru”
1
Toxic effects of G.Herbacium :
Especially the root bark and seeds are used in medicine.
Constituents:
Cotton seed meal contains from 0.0059 to 0.053% of phenolic compound named
gossypol. Some times it produces toxic effects. It is due to presence of gossypol. This
acts as a capillary poison resulting in local inflammation and edema.
Symptoms of slow poisoning by feeding experimental animals with cotton seed
meal consist of diarrhea, loss of appetite, emaciations, edema of lings, shortness of
breath, neuritis, paralysis.
The disturbances of digestion and nutrition are due to enteritis.
Recent investigation shows that cotton seed meal poisonings in pigs is probably
not due to a toxic substance in the cotton seed meal but is brought to a greater or lesser
degree from iron deficiency in an ill balanced diet.
Iron in the shape of ferric oxide appears to have an especially beneficial effect in
2
preventing the onset of symptoms .

90
References:
1. Poisonous plants of India by chopra (ICAR).
2. Mc Gowan and Crichton: Biochemistry ., 1924,18,273.
6.GO GRITHAM:
Ghee is obtained by clarification of milk fat at high temperature, Ghee is almost
anhydrous milk fat and there is no similar product in other countries. Cow milk
constitutes carotenoids due to this its colour is golden yellow colour. Because of its
pleasing flavour and aroma, ghee has always had a supreme status as an indigenous
product in India.
Properties:
RASA : Madhura
GUNA : Guru
VIRYA : Sheeta
VIPAKA : Madhura
KARMA : Rasayam, Vata pitta haram, Swaryam, Varnyam
Physiochemical characteristics:
Chemically, ghee is a complex lipid of glycerides(usually mixed),free fatty
acids,phospholipids,sterols,sterol esters,fat soluble vitamins, carbonyls, hydrocarbons,
carotenoids ,small amounts of charred casein and traces of calium,phosphorus,iron,etc. It
contains not more than 0.3% moisture,glycerides constitutes about 98% of the total
material,of the remaining constituets of about 2%sterols(mostly cholesterols)occur to the
extent of about 0.5%. Ghee has a melting range of 280 to 440 C.
Cow ghee can bond with lipid-soluble nutrients and herbs to penetrate the lipid
based cell walls of the body. This way it can transport the active components to the

91
interior of the cell where they impart the most benefit. This was mentioned in ayurveda as
Yogavahi.
Ghee made purely from Cows milk contains beta carotene, Vitamin E,rich source
of vitamin A,and vitamin D.It also contains butyric acid and fatty acid with antiviral and
anticancer properties.
“Gritham pittaanila haram rasa sukraoujasaam hitam

Nirvaapanam mridukam svaravarn prasaadanam”
(Charaka samhita Sutra.-13/14)
“Vatapitta prakritayo vatapittavikarinah
Chakshushkamaah kshataah ksheenah vriddhah balaasthatah balaah
Ayu prakarsha kamascha balavarna svararthinah
Pushtikamaah prajakamah soukumaryarthinachayo
Deeptoujasmriti medhaagni buddhindriya balaarthina
Pibeyusarpirarthascha daha shastra vishaagnibhih”
(“Charaka samhita Sutra-13/42-43)

92
PICTURES OF INDIVIDUAL DRUGS:
GUDUCHI APARAJITHA
SHATAVARI JATAMAMSI
GO GRITHAM
KARPASA

93
KARPASA BEEJAM SECTION CUTTING

KARPASA BEEJAM
“KARPAASA BEEJADI GRITHA GUTIKA”:
KARPASABEEJADI GRITHA GUTIKA KARPASABEEJADI GRITHA GUTIKA

94
MODE OF PREPARATION OF COMPOUND DRUG:

The compound prepared as a gutika/vati for the convience of the patient. This
Compound contains Guduchi, Aparajitha, Shatavari, Jatamamsi, Karpasa beejam and
“Go gritham”.
Guduchi, Aparajitha taken in the form of panchangam, Shatavari roots, Jatamamsi

Rhizome and Karpasa seeds were took for the preparation of the compound.
Guduchi and Aparajitha were dried in shadow area of the open air and made into
A fine powder. Shatavari roots, Jatamamsi rhizome and Karpasa seeds are made into a
fine powders by filtering through a cloth. All the powders are mixed in one vessel and Go
Gritha bhavana given one time and make it in to a pill of 500mg.
DOSAGE SCHEDULE:
Dosage schedule decided as 2 tablets (500mg each tablet), three times per a day
up to 45 days. Water used as an anupana for the intaking of the medicine.
RESTRICTIONS:
Each and every patient who undergone a trial for this drug are restricted not to
take excessive salt intake and other food items like pickles, papads, hot and spicy
Biryanis, fishes and eggs etc., and also advised for brisk walking for 40 min. daily.

95
CLINICAL STUDY:
My clinical study is “The effect of Karpasa beejadi Gritha Gutika” in the
management of Bhrama with special reference of Hypertension”.
This comprises the following:

1. Method and Material.
2. Observations and Result.
1.Method:
Thirty cases of adult patients with giddiness (Bhrama) and essential hypertension
were studied for clinical trial from the kaya chikitsa I.P.D and OPD at the post graduate
training and research department and Govt.Ayurvedic Hospital.
In this trial patients suffering from heart failure, malignant hypertension and
suffering from any other serious complications were excluded. However patients
suffering from pakshagatha were included in this study. The patients were examined
daily and the blood pressure was recorded with the help of a standard
sphygmomanometer.
In all the cases routine investigations of
1. CBP
2. CUE
3. Examination of blood urea, serum creatinine and blood sugar were conducted to the
extent possible.
The signs and symptoms, and the general condition of the patient before
commencement of treatment and the improvement noted daily/weekly (for O.P.patients)
was recorded. The bhrama condition was observed throughout the course, along with
headache, sleeplessness and fall on the ground. Grading was given for Bhrama, Headache
and Sleeplessness these gradings are observed from schedule initiation to end of the
schedule, for the convenience of the subjective parameter result assessment i.e.,
symptomatic relief in bhrama, headache and sleeplessness.

96
These symptoms are graded as follows

Bhrama:
Grade 0-No giddiness
Grade 1-Postural giddiness
Grade 2-Moderate giddiness
Grade 3-Severe giddiness
Headache:
Grade 0-No headache
Grade 1-Slight headache
Grade 2-Bearable headache
Grade 3-Unbearable headache
Sleeplessness:
Grade 0-Sound sleep
Grade 1-Mild Sleep
Grade 2-Moderate sleep
Grade 3- No Sleep.
In the schedule initiation, according to these gradings the symptoms are noted
along with other signs and symptoms. After completion of the trial again the general
condition along with these symptoms are noted and compared with the initial symptoms
and grading.
The improvement in the subjective symptoms is divided into four categories.
They are Mild improvement, Moderate improvement, Marked improvement and No
response. When patient response was less than 35% it was grouped into no response
category, if response is between 35%-50% it was grouped into mild response category, if
response is in between 50%-75% it was grouped into moderate category and if response
is greater than 75% it was grouped into Marked improvement category.

97
Inclusion Criteria:
(Based on “International Classification of Diseases -10”)
 Essential hypertension(Primary hypertension)

 High blood pressure.
 Hypertension- (arterial)(Benign)(Essential)(Malignant)(Primary)(Systemic).
Exclusion Criteria:
 Involving vessels of brain
-Sub Arachnoid Haemarrhage
-Intra Cerebral Haemarrhage
-Non-traumatic intracranial haemarrhage
-Cerebral infarction
-Stroke
-Cardio Vascular diseases
-Cardio vascular diseases.
-Sequel of Cardio vascular diseases.
 Involving vessels of Eye and Retinal disorders.

98
2.Material:
“Karpasa Beejadi Gritha Gutika” was used in this trial which contains
Guduchi, Aparajitha, Shatavari, Jatgamamsi, Karpasa beeja and Go gritha.
All the powders make into fine form by filtering it through a fine cloth of 100
mesh count. “Go gritha” bhavana given to these powders and dried then make into a pill
of 500 mg. This vati/ Gutika were used in the present trial.
Dosage:
Two tablets thrice daily for one week (42 tablets/week) given to patients for every
week until 7 weeks. Blood pressure was recorded for every week. The patients were
advised to take tablets 15-20 minutes after taking food.
If the hypertension severity was less, then used as 1 tablet three times a day.

99
OBSERVATIONS AND RESULTS:
Method of Assessment:
The clinical improvement in the relief of symptoms like Bhrama, Shirovedana,
Nidranasha and the improvement in the blood pressure was assessed. For the practical
purposes, the severity of hypertension is grouped as below.
S.No. Degree of hypertension Systolic blood Diastolic blood

pressure pressure.
1. Normal <120 <80
2. High normal 120-139 80-89
3. Stage I 140-159 90-99
4. Stage II >160 >100
For the convenience of the objective parameter result assessment i.e.,

spygomanometer readings. Each and every patient was categorized into normal/high
normal/stage I/stage II, before and after treatment. By using the above categories the
patient improvement was assessed. The assessment was divided into four categories.
They are No response, Mild improvement, Moderate improvement, and Marked
improvement.
Mild improvement was given when the patient stage of hypertension was comes
from i) Stage I to High normal
ii) Stage II to Stage I.
iii)High normal to Normal
Moderate improvement was given when the patient stage of hypertension was
comes from i) Stage I to Normal
ii) Stage II to High Normal.

100
Marked improvement was given when the patient stage of hypertension was
comes from i) Stage II to Normal.
No response when the patient stays in same stage before and after treatment.
In the present study, 38 patients were registered, out of which there were 8
dropouts during various stages of the clinical study. In 30 patients the clinical study was
completed.
OBSERVATIONS:
For the present clinical trial, 38 patients were selected from O.P/I.P.’s
P.G.Department of Kaya Cikitsa, Govt. Ayurvedic Hospital, Hyderabad, for the
evaluation of “Karpasa Beejadi Gritha Gutika”in the management of “Bhrama” w.s.r to
“Hypertension” Among them, there were 8 dropouts during the course with the
remaining 30 patients the clinical study was completed.
Epidemiological data:
Incidences were observed in 30 cases of Hypertension as per schedule described

earlier. The observations are shown in the tables as well as graphs.

101
1. INCIDENCE OF SEX:
Table No. 1 Showing the incidence of sex in 30 patients of Hypertension.
S.No. Sex No. of patients Percentage
1. Male 15 50%
2. Female 15 50%
showing the incidence of sex
Male
Female

102
2. INCIDENCE OF AGE:
Table No.2 Showing the incidence of age in 30 patients of Hypertension.
S.No. Age No. of Male No.of Percentage

group patients Female
patients
1. 1-25yr 2 0 6.66%
2. 26-35yr 0 2 6.66%
3. 36-45yr 3 2 16.66%
4. 46-55yr 7 4 36.66%
5. 56-65yr 2 5 23.33%
6. 66-75yr 1 2 10
Showing the incidence of age and sex in 30

patients of hypertension
M, 7
7
6
F, 5
5
F, 4
4
M
3 M, 3
F
M, 2 F, 2 F, 2 M, 2 F, 2
2
M, 1
1
F, 0 M, 0
0
1-25yr 26-35yr 36-45yr 46-55yr 56-65yr 66-75yr

103
3. INCIDENCE OF RELIGION:
Table No.3 Showing the incidence of Religion
S.No. Religion No. of patients Percentage
1. Hindu 25 83.33%
2. Muslim 5 16.66%
Showing the incidence of Religion
Muslim,17%
Hindu, 83% Hindu

Muslim

104
4. INCIDENCE OF MARITAL STATUS:

Table No.4 Showing the incidence of Marital Status in 30patients of
Hypertension.
S.No. Marital Status No. of patients Percentage
1. Married 28 93.33%
2. Unmarried 02 6.66%
Showing the incidence of marital status
2; 7%
Married
Unmarried
28; 93%

105
5. INCIDENCE OF OCCUPATION:
Table No.5 Showing the incidence of Occupation in 30 patients of Hypertension.
S.No. Occupation No. of patients Percentage
1. House wife 11 36.66%
2. Doctor 02 6.66%
3. Employ 09 30%
4. Labourer 07 23.33%
5. Students 01 3.33%
Showing the incidence of Occupation
12
10
6
11
9
4
7
2
2
1
0
Housewife Doctor Employ Labourer Student

106
6. INCIDENCE OF SOCIO-ECONOMIC STATUS:

Table No.6 Showing the pattern of Socio-Economic Status.
S.No. Socio-economic status No. of Percentage

patients
1. Low income group 18 60%
2. Middle income group 10 33%
3. High income group 2 7%
Showing the incidence of economical status
HIG, 2, 7%
LIG
MIG, 10, 33%
MIG
HIG
LIG, 18, 60%

107
7. INCIDENCE OF FOOD HABITS:

Table No.7 Showing the incidence of Diet
S.No. Diet No. of patients Percentage
1. Vegetarian 4 12.9%
2. Mixed 27 87.1%
Showing the incidence of Diet
Vegetarian, 6,
20%
Vegetarian
Mixed
Mixed, 24, 80%

108
8. INCIDENCE OF ADDICTIONS:
Table No.8 Showing the incidence of addictions.
S.No. Addiction No. of patients Percentage
1. Smoking Chewing 01 3.33%
2. Alcohol 03 10%
3. Alcohol+Tobacco smoking 02 6.66%
4 Alcohol+T.Smo+T.Chew 04 13.33%
5 T.Smok+T.Chew. 01 3.33%
6. Toddy+T.Chew. 01 3.33%
7. Alco.+T.Smok+Toddy. 04 13.33%
8. No addictions 12 40%
9. Toddy 05 20%

109
Incidence of addiction in 30 hypertension patients
14
12
12
10
8
6 5
4 4
4 3
2
2 1 1 1
0
l . .
g
ho ng w w w y. ns
y
in o i he he he dd io dd
he
w c ok C o t To
Al sm T. .C T.
C T di
c
C + +T + k+ ad
in
g co m
o
ok
dd
y o
ok ac S m No
b T. . Sm To T.S
Sm To l + T +
l + ho o.
o o lc
coh A
lc A
A l

110
9. INCIDENCE OF FAMILY HISTORY:
Table no.9 showing the incidence of Family history of Hypertension.
S.No. Family H/O. No. of patients Percentage

Hypetension
1. Yes 14 46.66%
2. No 16 53.33%
Showing the incidence of family H/o Hypertension
16
14
12
10
No, 16
8 Yes, 14
6
4
2
0
Yes No

111
10. INCIDENCE OF AVAILABILITY OF CASES:
Table No.10 Showing the incidence of availability of cases.
S.No. Availability No. of patients Percentage
1. Fresh 10 40%
2. On medication 20 60%
Showing the incidense of availability of cases
20
On
Medication
10
Fresh
0 5 10 15 20

112
11.INCIDENCE OF HABITATE:
Table No.11 Showing the incidence of Habitate.
S.No. Habitate No. of patients Percentage
1. Town 19 63.33%
2. Rural 9 30%
3. Urban 2 6.66%
Showing the incidence of habitate
20 19
18
16
14
12
10 9
8
6
4 2
2
0
Town Urban Rural

113
12. INCIDENCE OF SEVERITY BEFORE TREATMENT:
Table No.12 Showing the incidence of Type of Severity of hypertension

Before treatment.
S.No. Type of Severity No. of patients Percentage
1. High Normal 1 3.33%
2. Stage I 4 13.33%
3. Stage II 25 83.33%
Showing the severity of hypertension before

treatment
25
25
20
15
10
4
5
1
0
High normal Stage I Stage II

114
13. INCIDENCE OF OBESITY:
Table No.13 Showing the incidence of Obesity in thirty patients of hypertension.
S.No. Type of Obesity No. of Percentage

patients
1. Obese 11 36.66%
2. Non-Obese 19 63.33%
Showing the indidense of obesity in 30 patients of

hypertension
19
Non-Obese
11
Obese
0 5 10 15 20

115
14. INCIDENCE OF CHRONICITY:
Table No.14 Showing the incidence of Chronicity of Hypertension.
S.No. Chronicity No. of patients Percentage
1. Fresh 10 33.33%
2. 1m-6months 6 20%
3. 6m-1year 1 3.33%
4. 1yr-5yr 7 23.33%
5. 5yr-10yr 4 13.33%
6. 10yr-15yr 2 6.66
Showing the incidence of chronicity of

hypertension
12
10
10
8 7
6
6
4
4
2
2 1
0
Fresh 1mon- 6mon-1year 1yr-5yr 5yr-10yr 10yr-15yr
6months

116
15.INCIDENCE OF EDUCATION:
Table No.15 Showing the Incidence of Education in 30 patients of Hypertension.
S.No. Education No. of patients Percentage
1. Low Education 13 43.33%
2. High Education 6 20%
3 No Education 11 36.66%
Showing the incidence of Education
14 13
12 11
10
8
6
6
4
2
0
Low education High education No education

117
16.INCIDENCE OF PRAKRITI:
Table No. 16 Showing the pattern of Deha Prakriti in 30 patients of hypertension.
S.No. Deha Prakriti No. of patients Percentage
1. VATAPITTA 12 40%
2. PITTAKAPHA 7 23.33%
3. KAPHAVATA 3 10%
4. PITTAVATA 1 3.33%
5. KAPHAPITTA 4 13.33%
6. VATAKAPHA 3 10%
Showing the incidence of Prakriti in 30 patients

VP
40%
40
35
PK
30
23.33%
25
KP
20 KV VK
13.33%
15 10% 10%
PV
10
3.33%
5
0
PK KV VP KP VK PV

118
17.INCIDENCE OF STRESS:
Table No.17 Showing the incidence of Stress present in 30 hypertensive patients.
S.No. Nature of Stress No. of patients Percentage
1. No stress 4 13.33%
2. Psychological 19 63.33%
3. Psychological+Physical 7 23.33%
Showing the incidence of type of stress present in

patients
Physi+Psyco 7
stress 23.33%
19
Psychological 63.33%
stress
4
No stress 13.33%
0 10 20 30 40 50 60 70

119
18. INCIDENCE OF DIABETES MELLITIS ASSOCIATION:
Table No.18 Showing the presence of Diabetes mellitus.
S.No. Diabetes Mellitis No. of patients Percentage
1. Present 06 20%
2. Absent 24 80%
Showing the incidence of DM along with

Hypertension
30
24
25
20
15
10
6
5
0
Present Absent

120
19.INCIDENCE OF PATIENTS USING

OTHER MEDICATION:
Table No.19 Showing the Incidence of patients using allopathic drug along with trial
drug in 30 patients of hypertension.
S.No. Type of Drug No. of patients Percentage
1. No drug 09 40%
2. Beta blocker 7 23.33%
3. Beta 5 16.66%
blocker+CCB
4. CCB 4 13.33%
5. ARB+D 1 3.33%
6. CCB+D 1 3.33%
7. ARB 1 3.33%
8. ACEI 1 3.33%
9. Diretics 1 3.33%
CCB=Calcium channel blocker; ARB=Angiotensin II receptor blocker;D=Diretic

ACEI=Angiotensin converting enzyme Imhibitor.

121
Showing the incidence of using allopathic drug
ARB 1
ACEI 1
D 1
CCB+BB 5
CCB+D 1
ARB+D 1
CCB 4
BB 7
No drug 9
0 2 4 6 8 10

122
RESULTS:
Results were assessed on the basis of clinical (Subjective parameter) as well as
Sphygmomanometer readings (Objective parameter) after the treatment.
RESULTS OF SUBJECTIVE PARAMETERS:
BHRAMA
Table No.20
Total
Symptom ‘t’ ‘p’ Remarks
Grading Mean S.D.  S.E. value value
Score x-x
Mean
BT 2.5 1.6 0.50 0.09

17.58 0.000 S
AT 0.9 1.6 0.60 0.11

123
SHIRAH SHULA
Table No.21
Total
Symptom ‘t’ ‘p’
Grading Mean S.D.  S.E. value value Remarks
Score x-x
Mean
BT 1.96 1.13 0.55 0.10

14.29 0.000 S
AT 0.83 1.13 0.53 0.09
ANIDRA
Table No.22
Total
Score x-x
Mean
BT 0.86 0.50 1.00 0.18

4.35 0.000 S
AT 0.36 0.50 0.55 0.10
OVER ALL THE SYMPTOMS
Table No.23
Total
Score x-x
Mean
BT 5.33 3.23 1.24 0.22

19.72 0.000 S
AT 2.10 0.50 1.12 0.20

124
Table No.24 Results based on the Subjective parameters.
S.NO. Relief No. of patients Percentage
1. Marked 11 36.66%
2. Moderate 14 46.66%
3. Mild 3 10%
4. No relief 2 6.66%
Showing the results based on

subjective parameters
2, 7%
3, 10% Marked
11, 37%
Moderate
Mild
No relief
14, 46%

125
RESULTS OF OBJECTIVE PARAMETERS:
Table No.25 Showing the results Based on Systolic blood pressure.
Objective Mean % of Mean SD  SE ‘t’ ‘p’ Remarks

parameter relief of x-x value value
BT 158 16.96 3.09

S.B.P
0.000
AT 131 17.08% 27.33 18.88 3.44 16.50 S
showing the results of SBP before

and after treatment
200
150
BT
100
AT
50
0
1 4 7 10 13 16 19 22 25 28

126
Table No.26 Showing the results Based on Diastolic blood pressure.
Objective Mean % of Mean SD SE ‘t’ value ‘p’ Remarks

parameter relief of x-x  value
BT 103 9.43 1.72

D.B.P
12.62% 12.83 22.45 0.000 S
AT 90 9.14 1.66
showing the DBP before and after

treatment
140
120
100
80 BT
60 AT
40
20
0
1 4 7 10 13 16 19 22 25 28

127
Table No.27 Results based on Objective parameters.
S.NO. Relief No. of Percentage

patients
1. Marked 1 3.33%
2. Moderate 9 10%
3. Mild 14 46.66%
4. No response 6 20%
Showing the results based on

objective parameter.
No Marked
response 3%
20% Marked
Moderate
30% Moderate
Mild
Mild No response
47%

128
DISCUSSION:
“Bhrama” is one of the major symptom in hypertension. Along with bhrama other
symptoms like shirah shula and anidra etc., are associated in hypertension.Bhrama occurs
due to vata, pitta prakopa and rajo dosha adikyatha.
Hypertension is one of the many modern disorders of which no direct reference is

available in ayurveda. The symptomatology is available in rakta dushti lakshanas to some
extent, and few other in avritha vayu lakshanas,to some more in rasa dushti lakshanas,but
direct reference as a disease is not yet available.
Certain factors can be credited to cause highblood pressure which is within the
frame work of doshadhatu mala principle. It has been observed in earlier chapters that
prana, vyana, udana, sadhaka pitta,avalambaka kapha,manas,uro hridaya,rasa vaha, rakta
vaha,mutravaha srotas are the factors which play a vital role in the pathogenesis of
hypertension.
Pranavayu has a direct control on hridaya by its dharana capacity. Simultaneously

it controls manas and other higher mental faculties’ because of indriya and chitta dharana.
Indriyas are controlled by manas and manas by prana vayu as stated in hatha yoga
pradeepika. Apart from this, pranavayu has dharana capacity on dhamani as stated in
“Ashtanga sangraha”. Thus prana yauu has a triangular control on: i)Manas, indriyas
ii)Hrudaya and iii)Dhamani. Similarly vyana vayu is the guiding force behind rasa rakta
samvahana, ably assisted indirectly by apana vayu because of identical nature of their
functions. Vyana vayu helps sweda, asruk sravana or expulsion from the body where as
apana vayu helps in the explusion of mutra, mala etc., Ama resulting due to improper
metabolism at dhatwagni level, ama has been stated as a regulatory factor which causes
the accumulation of “Kledamsha” and “Snehamsha”in the dhamanis which causes the
decrease in the lumen of dhamani. This decreases or increases the peripheral resistance,
which in turn increases the load on heart resulting in increased cardiac output.

129
Since the causes for high blood pressure are increased cardiac output and
increased peripheral resistance, the role of prana vayu, vyana vayu and udana vayu is
quite evident.
Pranavayu being connected to the functional aspects in manas, hridaya and

dhamani tries to keep rasa, rakta etc., intact where as vyana vayu tries for sravana of rakta
and sweda by moving away from the body. Similarly apana vayu which is responsible for
the elimination of mootradi, is indirectly helping vayana vayu. That is why it has been
observed that two forces prana vayu on one hand vyana vayu and apana vayu on the other
hand, work in opposite directions. This is also evident from the observation in vijaya
rakshita commentary that prana is “Prakarshena anayati, jeevayati”i,e., that which carries
sensation from the body to the brain and which helps any substance to enter into the
body.
Apana is “Apanayati doorikarothi”i.e., that which carries orders from the brain to
body and which helps the substances expelling them out of the body. Vyana vayu is
clubbed in this functional aspect with apana, because it also expels out sweda and rakta.
Thus it is evident that these two act opposite to prana vayu.
The role of manas, Sadhaka pitta in causing hypertension is not insignificant. It

may be “Malinahara sheeela” or any other factor which will disturb the functional aspect
of “Manas”and “Sadhaka pitta”which is a complex of substances which are invariably
essential in connection with some of the higher mental faculties and emotional states.
These psychogenic factors are correlated with prana vayu which also is related to hridaya
and dhamanies and incidentally hridaya and dhamanies are also related to vyana vayu and
apana vayu. Here vyana vayu helps in rasa samvahanam and apana vayu trying to
eliminate the toxic substances like kledamsha etc.,(causing avarodham)through mootra.
The presence of Kledamsha and Snehamsha is related to ama and avalambaka

kapha, because ama has an invariable relation with kapha for its genesis, as kapha vridhi
disturbs dhatwagni vyapara as well causing ama genesis at dhatwagni level. Avalambaka

130
kapha is present in rasa itself. It is rasa which faces an avarodham for its samvahanam in
dhamanis because of sankocha in turn due to adhesion of kledamsha and snehamsha in
them.
Thus it is a vicious circle between the three vayus as stated earlier, Manas,
Sadhaka pitta, Avalambhaka kapha, and Ama which conjoined together more or less,
result in hypertension.
With these factors in view, the present compound “Karpasa Beejadi Gritha
Gutika” contains Guduchi,Aparajitha,Shatavari,Jatamamsi,Karpasa beejam and Go
gritham, have been considered as an ideal combination for samprapthi vighatana.
Guduchi is tridoshahara, immunomodulator, medhyakara and rasayana drug.

Guduchi is jwaraha which acts as swedajananakari which removes swedavarodham and
eliminated toxic substances by sweda. Guduchi was indicated in hridrogas by vanga sena.
It has deepaniya property which increase Agni helps in amapachanam and eliminates
kledamsha thus relieves srotavarodha and kledatva.
Aparajitha has katu, tikta, kashaya rasas, which acts as pittahara and medhyakara.
It is also indicated in shodha also. It is mentioned in manasika vikaras by Rajamarthanda.
Shatavari has madhura, tikta rasa, Sheeta virya and madhura vipaka.It is vatapitta hara
and rasayana drug. A high dose (60mg/kg) of shatavari produced a fall in blood pressure
and depression of the respiration. Its glycosidal faction produced bradycardia and
reduction in forces of contraction. Jatamamsi has tikta, kashaya, madhura rasas, sheeta
virya and katu vipaka which acts as tridoshahara and it has medhya property. It has a
depressant action on central nervous systerm. Which inturn reduces the blood pressure.
It’s aqueous extract and alkaloid extract also showed hypotensive effects on heart, it’s
root powder shows a sedative action, which in turn reduces the blood pressure.

131
Karpasa beeja has a property of katu rasa,ushna viryu and katuvipaka. It is

vatapitta haram, seeds acts as vrishya. It’s leaf powder mentioned as mutrala (diuretic). It
is indicated in muchra krichchra.
“Go gritha” which has madhura rasa, sheeta virya and madhura vipaka. It acts as
vatapitta hara and medhagnivardhakam. It increases the HDL Cholesterol hence it is a
cardioprotective. Acharya Charaka mentioned “Gritha” preparations in so many places
where the pitta lakshanas are aggravated in his chikitsa stana of charaka samhita.
The compound drug “Karpasa Beejadi Gritha Gutika” having the properties of
madhura, tikta, kashaya rasas, Guru snigdha gunas, Sheeta virya and Madhura vipaka
predominantly. Due to madhura, tikta and kahsaya rasas it acts as a vatapitta shamaka.
Most of the drugs are tridosha hara due to this reason this acts on tridoshas.
In the present clinical trial 10 patients are taken as fresh cases who are suffering
with bhrama and hypertension. 20 patients were already under the treatment of allopathic
prescriptions. But, they are suffering with bhrama associated without control on blood
pressure. All the 30 patients were divided into three categories according to JNC-VII
classification. I) high normal II) Stage I hypertension III) Stage II hypertension. One
patient comes under highnormal, in Stage I 4 patients and in stage II 25 patients.
After the seven weeks of medication, the result was assessed in two ways I) based
on subjective parameters II) based on objective parameter. Based on the objective
parameters the assessment gave results as mild improvement was seen in 14
patients(46.66%),moderate improvement was seen in 9 patients(30%),marked
improvement was seen in 1 patients(3.33%) and no response was seen in 6 patients(20%).
In that mild improvement was seen in 8 males and 6 females, moderate improvement was
seen in 3 males and 6 females, marked improvement was seen in 1 male and no response
was seen in 3 males and 3 females.

132
In mild and marked improvement groups males are more improved, whereas in
moderate improvement group females are more improved. In no response group both
males and females are equally responded.
Out of 30 patients 23 patients are in between the age group of 36-65 yrs. 70 % of
the patients are in Madhya vayah. This indicated the prevalence of the disease is more in
middle aged persons. In this age pitta prabhava is more. Pitta has an ashrayashrayi bhava
relation with rakta, which has a major key role in the genesis of bhrama (hypertension).
Among 30 patients 19 patients (63.33%) are from town area, nine patients (30%)
are from rural area and 2 patients(6.66%) belongs to urban area. Due to small sample size
of clinical research we cannot correlate with this habitat.
83%patients (25) belongs to Hindu religion and 17%(5) patients are belongs to
Muslim religion.
Among 30 patients 18 patients(60%) are belongs to minor income group,10

patients(33%) belongs to middle income group and only 2 patients (6.66%) are belongs to
high income group.
In 30 patients 11 patients (36.66%) belongs to obese category. Whose BMI >25

are categorized as obese patients. 19 patients (63.33%) are belongs to non obese category.
In Non obese patients the improvement is better than obese patients. In mild
improvement of obese group four males and one female was responded. Whereas in
moderate group three female patients were responded well, one male and two female
cases of obese patients were not responded. Non obese patients are responded well than
obese patients. In Non obese category 9 patients are improved mildly, 6 patients are
improved moderately, one patient improved markedly, Obese and nonobese patients are
equally responded in non obese category. 2 obese and 2 non obese patients are not
responded for the treatment except in symptomatic relief in bhrama, shirah shula and
anidra; subjective symptoms are relieved equally in obese and non-bese category.

133
Obesity is a close relation with hypertension. Hypertension is due to increased

cardiac output and increased peripheral resistance. Obesity causes arteriosclerosis which
in turn leads to lumen decrease in arteries and leads to hypertension.
Among 30 patients stress was observed. They categorized into no stress group,
psychological stress only group and physical and psychological stress group.
Improvement observed in these groups most of patients (19) belong to psychological
stress only group. In this group mild improvement was seen in 8 patients, moderate
improvement in 6 patients, marked improvement in 1 patient and no response was seen in
3 patients. In physical and psychological stress only group two persons were not
responded to treatment, five are responded mildly, one patient was responded moderately.
Physical and psychological stress causes anxiety in turn it causes secretion of

catacholamines into circulation which causes the vasoconstriction of blood vessels and
leads to hypertension.
All the thirty patients are divided as “Trial drug group”comprising of nine cases
and “allopathic drug using group”comprising of 21 cases. “In allopathic drug using
group” 7 patients are on betablockers, 5 patients are on calcium channel blocker plus
betablocker, 4 patients are on plain calcium channel blocker and remaining 5 patients are
on different classes of antihypertensive drugs. In ‘trial drug group’46.66 % of the patients
responded as mild improvement, 16.66% patients were responded as moderate
improvement, 3.33%patients were responded as marked improvement. In this group
almost all the fresh patients are responded subjectively and objectively. In “allopathic
drug using group” of 21 cases 33.33% of patients had mildly improved, 13.33% of
patients were moderately improved, 16.66% of patients are not responded even though
they are on continuation of trial drug and allopathic drug.
Among 30 patients of hypertension 10 patients were belongs to fresh category.

Who are diagnosed as hypertensive within one month, in this group 4 patients are mildly
improved,4 patients are moderately improved,1 patient was markedly improved and one

134
patient was not responded to the treatment even though he belongs to fresh group. Six
patients were belongs to the group “1month-6months”, in this group 3 patients were
responded mildly, two patients as moderately and one patient was not responded . One
patient belongs to the group of “6months-1 yr” chronicity was responded moderately.
Seven patients were belongs to the group of “1yr-5yr”chronicity, in this 5 patients
responded as mildly, one patient not responded. Four patients were belongs to the
chronicity group of “5yr-10 yr”, in this group one patient was responded as mildly, two
patients were responded as moderately, and one patient was not responded. In “10 yr-
15yr”group one patient was not responded and one patient was mildly responded.
After seeing all the chronicity groups, it was emphasized that all the chronic
sufferers of the hypertension were not responded well to the treatment. But, subjectively
all of them are relieved in symptoms satisfactorily.
Results according to deha prakriti,out of thirty patients twelve patients belongs to
VP prakriti, All the patients are responded in VP prakriti group. In this group, five
patients are mildly responded, five patients are moderately responded. Two patient were
not responded.
Seven patients belong to PK prakriti.Three patients improved mildly, one
patient was improved as moderately and three patients are not responded. Pittam has a
relation with rakta as ashrashrayi bhava relation. Pitta and Rakta prakopa may leads to
bhrama i.e., hypertension. Increase in sadrava pitta and rakta prakopa increase blood
volume in turn increases in cardiac output leads to hypertension. Increase in sadravapitta
leads to agnimandya then leads to ama formation.Which increases the viscosity of the
blood which increases peripheral resistance further leads to hypertension. This may be
the reason for the patients not responded in PK prakriti group.
Three patients belong to VK prakriti and three for KV prakriti, one patient
belongs to PV prakriti. In KP prakriti group also there is no marked improvement
patients. Only mild improved patients are three and one patient improved as moderately.
In VK prakriti group one patient is markedly improved, one patient was not
responded and one patient was mildly responded. In KV prakriti group on patient was
mildly improved, two patients were markedly improved.

135
All the thirty patients were divided into three groups according to their systolic
and diastolic blood pressures based on JNC-VII classification. These three groups are i)
high normal ii) Stage I hypertension group iii) Stage II hypertension group.
Twenty five patients belong to Stage II hypertension, four patients belong to
Stage I hypertension and one patient belongs to high normal. All the no response cases
are from stage II hypertension group only. The intensity of the disease (hypertension)
may be the cause for the no response in the patients of Stage II hypertension category.
According to Subjective parameter,i.e., relief in bhrama,shirah shula and
anidra,mild improvement was seen in 03 patients,moderate improvement was seen in 14
patients,marked improvement in 11 patients and no response was seen in two patients. In
each and every patient the symptoms were responded satisfactorily with or without
reduction in blood pressure.
Except one patient, she complained abdominal discomfort and bloating after in
taking of the tablets, all the other patients not complained any side effects after in taking
the tablets in course of seven weeks.
After stopping the drug occasionally some patients described giddiness with low
intensity when compare with the earlier bhrama.
LIMITATIONS OF THE STUDY:

 The sampling method was incidental and sample size was very small, so it is
difficult to generalize the results.
 Fluctuations of blood pressure when risk factors are consumed.
RECOMMENDATIONS FOR FUTURE STUDY:

 The same study can be conducted with large sample size.
 A comparative study of the Ayurvedic and allopathic drugs can be conducted.
 An effort should me made to understand our drugs in terms of ACE
inhibitors,Calcium channel blocker,α-blocker,β
-blocker,diuretics etc.,
 A study can be conducted with other therapies like shirodhara, basthi,
rakamokshana.

136
CONCLUSION:
In the present clinical trial “The effect of Karpasa Beejadi Gritha Gutika in tha
management of Bhrama w.s.r.to Hypertention”. 30 cases were studied , out of them 25
cases were having Stage II hypertension, four cases were having Stage I hypertension and
one case has Highnormal. Thus according to the severity of disease the patients were
divided into three groups.
Response to the treatment was classified as no response, mild improvement,

moderate improvement and marked improvement. According to Objective parameter i.e.,
blood pressure reading, In 25 cases of Stage II hypertension 1 case was responded
markedly, 7 cases are moderately, 11 cases are having mild improvement and six cases
were not responded in this group.
In four cases of Stage I hypertension two cases are showed as moderate

improvement and two cases are showed mild improvement.One case of high normal
responded as mild improvement.
According to Subjective parameter,i.e., relief in bhrama,shirah shula and

anidra,mild improvement was seen in 03 patients,moderate improvement was seen in 14
patients,marked improvement in 11 patients and no response was seen in two patients.
Signs and symptoms recorded before and after treatment the commencement of
the treatment have been reviewed finally at the end of the course. Symptoms like knee
joint pains, bronchial asthama and slurred speech associated with hemiplegia are not
responded within the 7 weeks of treatment. But, these conditions are improved when
compare with the schedule initiation.
In ‘Stage II degree of hypertension’ cases were responded well after two weeks of
treatment. In this group almost all the patients more or less responded well. But,
symptomatic relief was achieved within one week of treatment.i.e., relief in

137
bhrama,shirashula and anidra. In this group eleven patients were showed mild
improvement.
All the chronic patients more than five years of history were not responded well.
It may be due to chronicity of the disease. But, symptomatically they are also responded
well.
Thus to sum up the compound drug “Karpasa Beejadi Gritha Gutika” consisting
Guduchi,Aparajitha,Shatavari,Jatamamsi,Karpasa beejam and Go gritham, is useful in
cases of hypertension associated with giddiness(Bhrama). Symptomatically very effective
relief was achieved in Bhrama, Shirashula and Anidra.

138
SUMMARY:
The present clinical study conducted from the evaluation of the effect of “Karpasa
Beejadi Gritha Gutika” in the management of “Bhrama” w.s.r to Hypertension.
The word Hypertension explained in introduction. The history of hypertension
from ancient to present period, various references of bhrama and reasons for the disease
why it was not there in those days.
The explanation of definition of Hypertension; Shareera (Anatomy and
Physiology) and Nidana (Pathology) of Hypertension explained, according to ayurveda
and modern literature.
Consequences and pathogenesis of hypertension explained in disease aspect.
Management of Hypertension by modifying, the mental activity and the treatment
of Bhrama (Hypertension) are explained. Dietary restrictions as Pathya-Apathya are
explained.
The criteria for the selection of the drugs and botanical names, disriptions,
indications and uses of the drugs are explained in drug aspect.Importance of go gritha and
its utility in hypertension was explained.
The Number and nature of the cases teken-up for the clinical study has been
stated. Observation before, during and after treatment with results are recorded and
explained.
The results are divided into four categories they are mild improvement, moderate
improvement, marked improvement and no response.
The approach of disease Hypertension discussed. Hatayoaga and Bruhatriyi view
discussed. The effect of compound drug on Hypertension is discussed.
Total study of the disease, drug, and preliminary clinical work has been reviewed,
in a brief discussion. Results of the treatment showing the efficacy of the drug have been
stated effect of the treatment results on both sexes and different age groups Hypertensive
patients have been concluded. The utility of the study is out lined.

139
BIBLIOGRAPHY:
1. Acarya raghuvir Prasad trivedi, Charmaroga Nidarshika, Published by Shree

baidyanath ayurveda bhavan lig., Nagpur,Second resvised and enlarged edition.
2. Arunadatta and Hemadri(1998) “Astanga Hridaya,” Sarvanga sundara and
Ayurveda rasayana Sanskrit commentary ,Eight edition,Edr.Bhishagacharya
Harishastri paradakara vaidya, chaukhambha Sanskrit orientalia, Varanasi-01.
3. Astanga sangraha (1993), Hindi vyakhya Edr.Kaviraj atridev gupta, Reprint in
1993, Chaukhambha Sanskrit series office, Varanasi-01.
4. Anonymous adhamalla dipika and Gudartha dipika Sanskrit commentary (1983).
5. Sharangadhara samhita, Edr.PantditParashurama shastri, Vidyasagar, 3rd Edition,
Chaukhambha orientalia,Varanasii-01.
st
6. Ayurvediya panchakarma vignana (1990) Edr. Acharya mukundila dwivedi,1
Edition,Chaukambha Sanskrit pratisthan, Jawaharnagar,Delhi-7.
7. Ayurvediya panchakarma vignana (1999), Edr.Vaidya Haridas,Shridhar
kasture,Sri.Baidyanath ayurveda bhavan Ltd., Nagpur-9.
8. API text book of Medicine (1997) Edr. Gurmukh, Sainani, 5th Edition,Association
of physicians of India.Bombay.
st
9. Bhela samhita (1959).Edr.Shri.Girija dayalu, 1 Edition, Choukhambha vaidya
bhavan, Varanasi-1.
10. Bhaishajya ratnavali (1996), Vidyotini hindi teeksa, Edr.Shri Rajeshwara datta
shastri, 12th Edition, Chaukhambha Sanskrit sansthan.
11. Bhavaprakasha nighantu (2000), Pandit shri.Brahma shankara mishra, Seventh
Edition, Chaukambha Sanskrit bhavan, Varanasi-1.
12. Bhavaprakash of Shri Bhavamishra, Edt., with the vidyotini hindi commentary
by Bhishagratna pandit shri.Bhramashankar mishra(partII),Chaukhambha Sanskrit
sansthan,Varanasi-1.
13. Concise medical physiology by Chaudhary, 2nd Edition, Reprint (1995)new
central book agency(P)Ltd., 8/1,Chintamani das lane,Calcutta-09.

140
14. Chakrapani(2000)”Charaka samhita”,Ayurveda deepika Sanskrit

commentrary,Fourth Edition,Reprint,Edr., Vaidya yadavji trikamji
acharya,Choukhambha surabharati prakashan,Varanasi-1.
15. “Clinical hypertension”-proceedings of the international congress of
hypertension, Bombay.1977, Edr, Natoobhai.J.Shah, Padam shingvi.
th
16. Dalhana (1994), Sushritha samhita, Nibhanda sangraha, Sanskrit commentary,6
Edition,Edr.Vaidya Yadavji trikamji acharya,Chaoukhambha Sanskrit
orientalia,Varanasi-1.
17. Davidson’s principles and practice of medicine, by C.R.W.Edwards, 7th Edition.
18. “Essential hypertension” (1990) Edr.Dr.Norman M Kaplan, 6th Edition,East
preston street,Baltimore Maryland.USA,P.No.118.
th
19. Essentials of medical pharmacology by K.D.Tripathi,4 Edn,Updated
reprint(2001) Jaypee brothers,Medical publishers(P)ltd., New delhi-02.
20. “Gray’s Anatom”y, edited by Peter Williams, Roger warwick, Mary dyson,
Lawrence Bannister, 37th Editon (1992), ELBS with Churchill living stone.
21. Gerard J tortora, “Principles of anatomy and physiology”, 8th Edn,Sandra
Reynolds grabowski,Purdeu University.
22. “Harrison’s principles of internal medicine”(2001),Kenneth,D.Brandt,VolumeII
Edition,Edr.Authomy,S.FAuci,Joseph,B.,Mc.Grawhill,Health provision
division,Newyork.
23. “Hutchisnon’s clinical methods” (2002) 21 st Edition, Edr, Michael swash, W.B.
Saunders company Ltd., London.
24. “Human anatomy” (1995), Edr.B.D.Chaurasia, Vol I, 3rd Edition CBS Publishers
and distributors, New delhi-02.
25. “Human Physiology”(1985),Vol I,By
E,Babsky,B.Khodorov,G.Kositsky,A.Zubkov,Edt., by E.B.Babslu,MIR Publishers
,Moscow.
26. “Kashyapa samhita or Vrddajeevakeeya tantra”(1994).By Vriddha
jeevaka,Vidyotini hindi commentary,Revised by vatsya,Choukhambha Sanskrit
sansthan,Varanasi-01.

141
27. “Madhavakara, Madhava nidanam, Madhukosha commentary” of vijayarakshita

and shrikantadatta, Vimala and Madhudhara, Hindi commentary of
Dr.Brahmananda, Tripathi, Published by Chaukhambha surabharati
prakashana.New edition.2000.
th
28. “Medicine for students”(1997)Edr.Asif.E.Golwalla,17 Edition,The national book
dept.Eros building, Churchgate,Mumbai-20.
nd
29. “Mosby’s guide to physical examination” by Seidel,Ball,Dains,Benedict,2
Edition(1991) ,Mosby,Year book.
30. Monier monier Williams (1970) “Sanskrit English Dictionary”, First edition,
Delhi,Varanasi, Motilal Banarasidas.
31. “Parishadhyam shabdhartha sahreeram”, Edt by Pandit damodara sharma gowda,
nd
Published by Shri.Baidyanath ayurveda bhavan, Nagpur, 2 edition.1979.
32. Priyavrit sharma, “Dravyaguna vignana”, Vol I&II , Published by Chowkhambha
th
Sanskrit samsthana,13 edition,1992.
33. P.J.Mehta’s “Practical medicine for students and practitioners”(1997)Edr.Late
pradip J Mehta,12 th Edition.
34. “Pharmacology and pharmacotherapeutics” (1988), Edr.R.S.Satoskar and
S.D.Bhandarkar,Revised 11th Edition ,Popular prakashan private limited,Bombay-
34.
35. “Raja niganthu” ed.By Tripathi, ID, Krishnadas academy, Varanasi 1982.
36. “Robbin’s pathologic basis of disease”,6/e Cotran,Kumar and Collins,6 th
Edition(2001),saunders,Harcourt,India.
37. “Shabda kalpa druma”(1967)Sanskrit dictionary,Rajaradha
kantadeva,Chowkhambha Sanskrit series,Varanasi-1.
38. “Shareera kriya vignanam, Physiology in ayurveda” by Dr.M.Ramasundar rao,2nd
editin,1994,Vijayawada.
st
39. “Text book of medical physiology”(1998).Edr.Arthur C.Guyton,1
edition,W.B.Sounders company,USA.
40. “Text book of pathology”,4th edition(2000),Harshmohan,Jaypee brothers,Medical
publishers(P)ltd.,New delhi.

142
41. “Vachaspathyam” (1970), Brihat samskruta bhidhanam Choukhambha Sanskrit

series, P.Box No.8, Varanasi-1.
42. “Vagbhata, Rasaratna samuchchaya”, Edt.By Kaviraj Sri.Ambikadata shastri,
published by chowkhambha amarabharati prakashana, Varanasi,7 th edition,1983.
43. “Yogaratnakara with vidyotini,Hindi commentary” by vaidya lakshmipathi
shastri,edt.By Bhishagratna Brahma Shankara shastri,Published by
th
Chowkhambha Sanskrit samsthan,Varanasi,5 edition,1993.
44. “Kaya chikitsa” Vol I by Ganga satyam and others, Published by Andhra Pradesh
ayurvedic literature improvement trust,1 st edition,1989.
45. “Roga vignan and Vikriti vignan” Vol I and Vol II by Dr.P.sheshireddy,
Published by Andhra Pradesh ayurvedic literature improvement trust, 1st
Edition,1990.
46. “Kaya chikitsa”Vol II by Dr. Ganjam purushottamacharyulu, Published by
Andhra Pradesh ayurvedic literature improvement trust, 1st Edition, 1989.
47. “Charaka samhita”by Nudurupati vishwanatha shastry, Published by Vavilla
ramaswami and sons,1st Edition, 1939.
48. “Dravya guna vigananam”by Dr.J.L.N.Shastry, Published by Choukhambha
orientalis, Varanasi-1.
49. “Ayurveda chikitsa siddantalu” by Dr.P.B.A.Venkatacharyulu, Published by
Atreya chikitsa parishad, 1st Edition,1987.
50. “Sharanagadhara samhita” by Vavilla ramashastrulu and sons, Madarasu.
51. “Current Medical Diagnosis and Treatment” edit by Laurance, Stephen, Maxina,
44th Edition,2005,Published by The Mc Graw hill company.
52. “Ashtanga sangraha of Vagbhata” Vol I/II/III by K.R.Srikantha murthy,
Published by Choukhambha orientalis, 2nd Edition, 2000.
nd
53. “Indian medicinal plants”by Kirthikar and Basu.2 Edition, 1935; Reprint 1975.
th
54. “Stedman’s Medical dictionary” 25 Edition, Published by Willians and Wikins.
55. Olivria SA,lepuerta P,Mc carthy BD,et al.Physician-related barriers to the
effective management of uncontrolled hypertension.Archives of internal
medicine,Feb 25,2002;162(4):413-420.

143
56. Benetos A,Thomas f,Bean K,et al.Prognostic value of systolic and diastolic blood
pressure in treated hypertensive men.Archives of internal
medicine,March11,2002;16;(5):577-581.
57. Hypertension and exercise by paul sorace, M.S.,RCEPsm.
58. Hypertension treatment and the prevention coronary heart disease in the elderly
by Marvin Moser, MD. Yale university school of medicine, new haven
Connecticut.
59. Kannel WB,GordonT,Schwartz MJ.Systolic versus diastolic blood pressure and
risk of coronary heart .The Framingham study.Am J Cardiol 1971;27:335-46.
60. MoserM.Clinical management of hypertension.3d ed.Caddp, Okla.:Professional
communications.
61. Moser MGrellet K, Okin P,Hodas A,HamillE,Rudick J.Long term management of
hypertension.
62. Medical research council trial of treatment of hypertension in older adults:
Principal results.Br Med J 1992; 304-405-12.
63. Treatment of mild hypertension study research group. Treatment of mild
hypertension study final results JAMA 1993; 270; 713-724.
64. Kaplan NM.Critical comments on recent literature.SCraaphy about maphy from
happhy.Amer J, Hypert.1988;1;428-430.
65. Gupta R.Meta-analysis of prevalence of hypertension in India. Indian heart
Journal 1997; 49:43-8.
66. Das SK, Sanyal K,Basu A.Study of urban community survey in India; growing
trend of high prevalence of hypertension in a developing country.Int.J Med
Sci2005 2:70-8.
67. Rose GA,Black burnH,Gillium RF,PrineasRJ.Cardiovascular survey methods.2 nd
Edition,WHO monograph series 1983;56.WHO Geneva.
68. The sixth report of the Joint National Committee on prevention, detection,
evaluation and treatment of high blood pressure.Arch Intern Med1997;157;1413-
46.
69. Park K. Park’s text book of preventive and social medicine. 18 th Edition, Jabalpur,
Bhanarsidos bhanot2005;216-318.

144
70. Singh RB, Sharma JP, Rastogi V, Niaz MA,Singh N. Prevalence and determinants
of hypertension in the Indian social class and heart
survey.J.HumHypertens1997;11:51-6.
71. Gupta R. Life style risk factors and coronary heart disease prevalence in Indian
men.J.Assoc Physians India 1996; 44:689-93.
72. Gupta R,Prakash H,Gupta VP,Gupta KD,Prevanence and determinants of
coronary heart disease in a rural population of India J clin Epidemiol
1997;50:203-9.
73. Ian B.Wilkinson, W.Stephen Waring,John R Cockroft,Your questions answered
hypertension, first edition, Published by Churchill living Stone.
74. Caraka Samhita with English Translation based on Chakrapani Datta’s Ayurveda
Deepika, by Vaidya Bhagavan Das & Dr. R.K.Sharma, Choukhamba Sanskrit
th
Series, Varanasi, 6 Edn, (1999).
75. Caraka Samhita with English Translation by Prof. P.V.Sharma, Choukamba

th
Orientalia, Varanasi, 6 Edn, (2001).
76. Desai R.R., Nidana Cikitsa Hastamalak, Shree Baidyanath Ayurveda Bhavan Pvt.
Ltd., Calcutta, 6 th Edn, (1985).
77. Dwarakanath.C, Introduction to Kaya Cikitsa; Choukamba Orientalia, Varanasi,

3rd Edn, (1996).
78. Chakrapani, commentary on Caraka Samhita; Nirnaya Sagar press, Mumbai, 2 nd

Edn.
79. Dwarakanath.C, Digestion and Metabolism in Ayurveda, Choukamba Krishna

Das Academy, Varanasi (2003) reprint.
80. P.V.Sharma; History of Medicine in India; Indian National Science Academy,

st
N.Delhi, (1992) 1 reprint.
81. Davidson’s principles and practice of Medicine, Churchill Living Stone, An

Imprint of Elsevier Science Ltd., 19 th Edn. (2002).
82. A.P.I. Text Book of medicine; Association of Physicians of India, Mumbai, 7 th

Edn. (2003).
83. Subrahmanya Sastry.V.V.; Tridosha theory, Supplement to Ayurvedic Seminar –

XIV, Arya Vaidya Sala, Kottakkal. (1977).

145
84. Subrahmanya Sastry.V.V.; Essentials of Basic Ayurvedic Concepts; Publication

Division, P.G. & Research Center, Sri. D.G.Malmalagi Ayurvedic Medical
College, Gadag (1999).
85. Nadkarni.K.M, Indian Materia medica, Popular Prakashan Pvt. Ltd., Bombay,
Second reprint of 3rd revised Edn, 1982.
86.Warrier.P.K, V.P.K.Nambair, C.Ramankutty; Indian Medicinal Plants,

(Vol-5); Orient Longman Ltd.; Madras, Reprint (1996).
87. Monier Williams; A Sanskrit English Dictionary; University Press Oxford, 1st
Edn. (1956).

146
DR.B.R.K.R.GOVT.AYURVEDIC COLLEGE.
S.R.NAGAR, HYDERABAD-500038.
POST GRADUATDE DEPARTMENT OF KAYACHIKITSA.
SPECIAL CASE SHEET FOR EVALUATION OF “KARPASABEEJADI

GRITHA GUTIKA” IN THE MANAGEMENT OF ‘BHRAMA’ WITH
SPECIALREFERENCE TO “HYPERTENSION”.
S.No :
Name : Case : OP/IP
W/o d/o s/o: O.P.Regd.No :
Age : D.O.A :
Sex : D.O.D :
Occupation:
Address :
Income :
1 Chief complaint with duration:
2) Associated symptoms:
3) History of Present illness:
4) History of Past illness:
5) Treatment history:
6) Family history: 1.Mother:

2. Father:
3. Married/Unmarried
4. Children:
5. Any other congenital disorders:
7) Personal History:
Haibits :
Addictions :
Alcohol/Tobaccosmoking/Chewing/Toddy/Cannabis/Noaddiction.
Diet : Mixed/Veg.
Socioeconomic status:LIG/MIG/HIG
8) Presence of risk factors: i) Smoking

ii) Diabetes
iii) Physical inactivity
iv) BMI/BWI
v) Alcohol

147
9) Psychological factors:
i) Stress-Physical
ii) Stress-Psychological
iii) Type of Job : Private/ Govt./ Individual/ Un employ
iv) Education : Low education/ High education/ No education
10) Physical examination:
a) Inspection:
b) Palpation:
c) Percussion:
d) Auscultation:
e) General Examination:
BP :
PR :
RR :
TEMP :
WEIGHT :
LIVER :
SPLEEN :
HEART :
LUNG :
f)Dasha vidha Pariksha:
PRAKRITHI SAMHANANA
VIKRITHI AHARASHAKTHI
SAARA VYAYAMASHAKTHI
SATMYAM VAYAH
SATVAM PRAMANAM
g)Ashatastana Pariksha:
NADI SHABDHA
MALA SPARSHA
MUTRA DRIK
JIHWA AKRITHI
h)Srotopariksha:
RASAVAHA SHUKRAVAHA
RAKTAVAHA PRANAVAHA
MAMSAVAHA UDAKAVAHA
MEDHOVAHA ANNAVAHA
ASTHIVAHA SWEDAVAHA
MAJJAVAHA ARTAVAVAHA

148
FOLLOWUP:
INVESTIGATIONS 1ST 7TH 14TH 21ST 28TH 35TH 42ND 49 TH
DAY DAY DAY DAY DAY DAY DAY DAY
BP
CBP
CUE
BODY WEIGHT
LIPID PROFILE
ESR
B.UREA
S.CREATININE
B.SUGAR
ECG
BMI
BWI
LFT
BS/BP
Conclusion :
Result :
Signature of the Guide
Signature of the Co-Guide.
INFORMED CONSENT
I______________________________son/daughter/wife of
____________________________am exercising my free will to participate in above
study as a subject. I have been informed to my satisfaction, by attending physician the
purpose of clinical evaluation and the nature of the drug treatment. I also aware of my
right to opt out of the treatment schedule, at any time during the course of the treatment.
Patient signature.
Schedule Initiation:
Result: Responded/Not responded/Discontinued.
Siganature of the Co-guide. Signature of the Guide.

My commitment increases my level of energy. My energy increases my level of action. My
action increases my level of success. My success increases my level of commitment.
Research in any field is the most important section of development. Ayurveda is in

service is for ages to the needy mankind to relieve their ailments and recording the facts
for the future generations. At present the Ayurveda research scholar, developing the
Ayurveda and understanding under the limelight of contemporary scientific backgrounds.
The plagiarism is more and more now a day in the scientific community. This is
happening as the researches of the various institutions are not available for the common
researcher. We wish to control this plagiarism by contributing the dissertations for
scientific community. If you find any thesis is a copy of the previous publication, we take
this issue to the university authorities for proper action. The solution to prevent copy cats
is … http://ayurvedaresearch.wordpress.com/
Dr. Shiva Rama Prasad Kethamakka

technoayurveda@gmail.com,

Effect of KBGG in The Management of Bhrama (Hypertension)

Caricato da

Informazioni sul documento

Titolo originale

Copyright

Formati disponibili

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

Formati disponibili

Effect of KBGG in The Management of Bhrama (Hypertension)

Caricato da

Copyright:

Formati disponibili

“THE EFFECT OF “KARPASA BEEJADI GRITHA GUTIKA” IN

THE MANAGEMENT OF BHRAMA W.S.R. TO HYPERTENSION”

Dissertation submitted in partial fulfillment for the degree of

DOCTOR OF MEDICINE (AYURVEDA)

Dr. V. VIJAYA BABU.

Dr. N.T.R UNIVERSITY OF HEALTH SCIENCES, VIJAYAWADA

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Date: Dr. V. VIJAYA BABU

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Date: Dr.PRAKASH CHANDER

created by technoayurveda.wordpress.com of Dr.KSRPrasad

I convey my wholehearted thanks and sincere respect to Dr. V.V.S.Ramashastry,

I take this opportunity to express my sincere thanks to Dr P. Nageswar Babu, Dr. S.

I am thankful to Dr. V.L.N.Shastry, Superintendent, Govt.Ayurvedic Hospital,

I am highly thankful to Dr. V. Anantsayanachari, HOD of P.G. Dept. of S.S.P and

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Dr.B. Arun kumar.

created by technoayurveda.wordpress.com of Dr.KSRPrasad

S.No. Title of the table Page No.

created by technoayurveda.wordpress.com of Dr.KSRPrasad

1) Anatomy of Heart and Blood vessels. 08

PART-B: Disease Aspect

1) Nirukthi & Paribhasha of “Bhrama” 29

created by technoayurveda.wordpress.com of Dr.KSRPrasad

1) Criteria for the selection of the drugs 83

PART-D: Clinical study.

1) Materials and Methods 95

created by technoayurveda.wordpress.com of Dr.KSRPrasad

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Hypertension which pertains to sakhas (tissues) is a bahyaroga marga disease.But

The present study is “The Effect of Karpasabeejadi Gritha Gutika” in the

created by technoayurveda.wordpress.com of Dr.KSRPrasad

PURANA AND UPANISHA PERIOD:

created by technoayurveda.wordpress.com of Dr.KSRPrasad

According to one of the well known modern physiology author dr.choudhary in

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Acharya charaka and sushritha have explained beautifully regarding approach of

created by technoayurveda.wordpress.com of Dr.KSRPrasad

This period has been regarded as an “era of inflorescence” of Indian medicine.

In this period we find books like madhava nidana, sharangadhara, yogaratnakara

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Presently hypertension is the major risk factor in the development atherosclerotic

created by technoayurveda.wordpress.com of Dr.KSRPrasad

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Relation of Hridaya with Doshas:

Hridaya and udana vayu

Hridaya and prana vayu

Hridaya and Vyana vayu

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Hridaya, Sadhaka pitta and Manas

Hridaya and Avalambaka Kapha

Relation of Hridaya with Ojas

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Heart is a conical, hollow muscular organ, situated in middle mediastinum. It is

created by technoayurveda.wordpress.com of Dr.KSRPrasad

Parasympathetic nerves reach via the vagus. These are cardioinhibitory; on

created by technoayurveda.wordpress.com of Dr.KSRPrasad

12. Cha.sam.Chi-28/6; Asta.Hri.Su-12/4

created by technoayurveda.wordpress.com of Dr.KSRPrasad

ANATOMY OF BLOOD VESSELS:

A Bird view on views and considerations of different acharyas on sira,dhamani

created by technoayurveda.wordpress.com of Dr.KSRPrasad

been used with the jnyanatantuvu8.